Glymphatic failure as a final common pathway to dementia
Open accessAbstract
Sleep is evolutionarily conserved across all species, and impaired sleep is a common trait of the diseased brain. Sleep quality decreases as we age, and disruption of the regular sleep architecture is a frequent antecedent to the onset of dementia in neurodegenerative diseases. The glymphatic system, which clears the brain of protein waste products, is mostly active during sleep. Yet the glymphatic system degrades with age, suggesting a causal relationship between sleep disturbance and symptomatic progression in the neurodegenerative dementias. The ties that bind sleep, aging, glymphatic clearance, and protein aggregation have shed new light on the pathogenesis of a broad range of neurodegenerative diseases, for which glymphatic failure may constitute a therapeutically targetable final common pathway.
AI snapshot
Written from the paper’s full text.
TL;DR
This review proposes that sleep-dependent glymphatic clearance fails with aging and neurodegenerative disease, allowing protein waste to stagnate and aggregate. It argues that glymphatic failure may be a shared, therapeutically targetable final pathway linking sleep disruption, vascular disease, and dementia.
Key findings
- Glymphatic transport is active mainly during NREM sleep and correlates with slow-wave activity; it declines with age and disease. In aged wild-type mice, influx of larger CSF tracers fell by as much as 85%, and human contrast clearance was inversely related to age.
- Protein aggregation may be driven by stagnant extracellular flow rather than solely by synaptic spread. The regional patterns of amyloid-beta, tau, and alpha-synuclein deposition overlap with glymphatic CSF inflow routes and with trapping of intrathecal contrast agents.
- AQP4 water channels in astrocytic endfeet are required for glymphatic flow. AQP4 deletion worsened amyloid plaques and memory deficits in APP/PS1 mice, and human AQP4 variants have been linked to sleep slow-wave activity, daytime sleepiness, amyloid burden, and rate of cognitive decline.
- Cardiovascular pulsatility helps drive CSF movement. Hypertension, small vessel disease, heart failure, and diabetes are associated with impaired glymphatic transport, potentially connecting vascular dementia and Alzheimer’s disease.
Methods
- Review/synthesis, not primary research. It integrates rodent and human studies on sleep, glymphatic and meningeal lymphatic clearance, AQP4, protein aggregation, and cardiovascular disease.
- The main analysis is conceptual: it compares published findings on glymphatic flow, aggregate spread, and vascular risk to propose a final common pathway. No new data, sample, or statistical analysis are reported.
Limitations
- The authors state that CNS flow vectors remain incompletely understood and more work is needed to account for all clearance paths; it is unclear whether oligomers or larger aggregates are the principal toxic species; and future work should determine whether sleep disturbances before diagnosis contribute to seeding and whether later sleep disturbances accelerate spread.
- Evident from the text: as a review, it relies on cited animal models and human observational/imaging studies, and several central claims—such as glymphatic failure as a causal final pathway and as a therapeutic target—are presented as hypotheses rather than tested in the paper.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 146 cited sources checked · 0 supported · 0 flagged
- Premisecitation
The glymphatic system degrades with age.
“Yet the glymphatic system degrades with age, suggesting a causal relationship between sleep disturbance and symptomatic progression in the neurodegenerative dementias.”
- Also stated in: § Why do proteins aggregate in neurodegenerative diseases? · plain
“The decrease in glymphatic flow in old mice is in part mediated by mislocation of AQP4 water channels away from the vascular wall (52)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [52] Kress BT, Impairment of paravascular clearance pathways in the aging brain. Annals of neurology 76, 845– 861 (2014). 25204284 PMC4245362 source
Not checked in the free run.
- Also stated in: § Why do proteins aggregate in neurodegenerative diseases? · plain
- Interpretationreasoning
Sleep disturbance is causally related to symptomatic progression in neurodegenerative dementias.
“suggesting a causal relationship between sleep disturbance and symptomatic progression in the neurodegenerative dementias”
Quote in the paperSubstantial claim - Interpretationreasoning
Glymphatic failure may be a therapeutically targetable final common pathway for neurodegenerative diseases.
“for which glymphatic failure may comprise a therapeutically targetable final common pathway”
Quote in the paperNot a substantial claim - Premisecitation
Glymphatic flow appears to stop with the onset of wakefulness.
“Fluid flow through the glymphatic system is thus inextricably linked with sleep, to the extent that flow appears to stop with the onset of wakefulness.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [35] Xie L, Sleep drives metabolite clearance from the adult brain. Science 342, 373– 377 (2013). 24136970 PMC3880190 source
Not checked in the free run.
- cites [36] Hablitz LM, Increased glymphatic influx is correlated with high EEG delta power and low heart rate in mice under anesthesia. Sci Adv 5, eaav5447 (2019). 30820460 PMC6392807 source
Not checked in the free run.
- Premisecitation
Meningeal lymphatic vessels in the dura drain brain interstitial CSF.
“two other groups reported that classical lymphatic vessels draining brain interstitial CSF might also be identified in the dura – the fibrous external layer of the meningeal membranes (39, 40).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [39] Louveau A, Structural and functional features of central nervous system lymphatic vessels. Nature 523, 337– 341 (2015). 26030524 PMC4506234 source
Not checked in the free run.
- cites [40] Aspelund A, A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules. The Journal of experimental medicine 212, 991– 999 (2015). 26077718 PMC4493418 source
Not checked in the free run.
- Premisecitation
Lymphatic vessels undergo atrophy in aging.
“lymphatic vessels undergo atrophy in aging (48, 49)”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [48] Scallan JP, Zawieja SD, Castorena-Gonzalez JA, Davis MJ, Lymphatic pumping: mechanics, mechanisms and malfunction. The Journal of physiology 594, 5749– 5768 (2016). 27219461 PMC5063934 source
Not checked in the free run.
- cites [49] Jakic B, Kerjaschki D, Wick G, Lymphatic Capillaries in Aging. Gerontology, 1– 8 (2020). 32580201 source
Not checked in the free run.
- Interpretationcitation
A large proportion of brain waste proteins and metabolites might pass through and be cleared by cervical lymphatics.
“Accordingly, a large proportion of brain waste proteins and metabolites might then be expected to pass through, and be cleared, by the cervical lymphatics.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [47] Pappolla M, Evidence for lymphatic Abeta clearance in Alzheimer’s transgenic mice. Neurobiology of disease 71, 215– 219 (2014). 25102344 PMC5589075 source
Not checked in the free run.
- Premisecitation
Aging is associated with a steep fall in glymphatic flow in rodent and human brains.
“Aging is also associated with a steep fall in glymphatic flow in the brains of both rodents and humans.”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [50] Da Mesquita S, Functional aspects of meningeal lymphatics in ageing and Alzheimer’s disease. Nature 560, 185– 191 (2018). 30046111 PMC6085146 source
Not checked in the free run.
- cites [52] Kress BT, Impairment of paravascular clearance pathways in the aging brain. Annals of neurology 76, 845– 861 (2014). 25204284 PMC4245362 source
Not checked in the free run.
- cites [53] Benveniste H, The Glymphatic System and Waste Clearance with Brain Aging: A Review. Gerontology 65, 106– 119 (2019). 29996134 PMC6329683 source
Not checked in the free run.
- cites [54] Zhou Y, Impairment of the Glymphatic Pathway and Putative Meningeal Lymphatic Vessels in the Aging Human. Annals of neurology 87, 357– 369 (2020). 31916277 source
Not checked in the free run.
- Premisecitation
CSF inflow of larger tracers is reduced by up to 85% in aged wild-type mice.
“CSF inflow of larger tracers are reduced by up to 85% in aged wild-type mice”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [50] Da Mesquita S, Functional aspects of meningeal lymphatics in ageing and Alzheimer’s disease. Nature 560, 185– 191 (2018). 30046111 PMC6085146 source
Not checked in the free run.
- cites [52] Kress BT, Impairment of paravascular clearance pathways in the aging brain. Annals of neurology 76, 845– 861 (2014). 25204284 PMC4245362 source
Not checked in the free run.
- cites [53] Benveniste H, The Glymphatic System and Waste Clearance with Brain Aging: A Review. Gerontology 65, 106– 119 (2019). 29996134 PMC6329683 source
Not checked in the free run.
- cites [54] Zhou Y, Impairment of the Glymphatic Pathway and Putative Meningeal Lymphatic Vessels in the Aging Human. Annals of neurology 87, 357– 369 (2020). 31916277 source
Not checked in the free run.
- Premisecitation
Most age-related primary neurodegenerative diseases involve disorders of protein processing and aggregation.
“Importantly, most of these age-related primary neurodegenerative diseases involve disorders of protein processing and aggregation.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [59] Soto C, Unfolding the role of protein misfolding in neurodegenerative diseases. Nature reviews. Neuroscience 4, 49– 60 (2003). 12511861 source
Not checked in the free run.
- Premisecitation
Infusion of amyloid-β into CSF acutely reduces glymphatic activity in wild-type mice, suggesting a direct toxic effect.
“Infusion of amyloid-β into CSF acutely reduced glymphatic activity in wild-type mice suggesting a direct toxic effect (50, 55).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [50] Da Mesquita S, Functional aspects of meningeal lymphatics in ageing and Alzheimer’s disease. Nature 560, 185– 191 (2018). 30046111 PMC6085146 source
Not checked in the free run.
- cites [55] Peng W, Suppression of glymphatic fluid transport in a mouse model of Alzheimer’s disease. Neurobiology of disease 93, 215– 225 (2016). 27234656 PMC4980916 source
Not checked in the free run.
- Premisecitation
Contrast clearance in human brain tissue is inversely correlated with age in all subjects studied.
“while contrast clearance in human brain tissue was inversely correlated to age in all subjects studied (50, 52–54).”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [50] Da Mesquita S, Functional aspects of meningeal lymphatics in ageing and Alzheimer’s disease. Nature 560, 185– 191 (2018). 30046111 PMC6085146 source
Not checked in the free run.
- cites [52] Kress BT, Impairment of paravascular clearance pathways in the aging brain. Annals of neurology 76, 845– 861 (2014). 25204284 PMC4245362 source
Not checked in the free run.
- cites [53] Benveniste H, The Glymphatic System and Waste Clearance with Brain Aging: A Review. Gerontology 65, 106– 119 (2019). 29996134 PMC6329683 source
Not checked in the free run.
- cites [54] Zhou Y, Impairment of the Glymphatic Pathway and Putative Meningeal Lymphatic Vessels in the Aging Human. Annals of neurology 87, 357– 369 (2020). 31916277 source
Not checked in the free run.
- Premisecitation
In human subjects, efflux of CSF containing amyloid-β and phospho-tau is reduced in patients with Alzheimer disease compared to age-matched controls.
“in human subjects, efflux of CSF containing amyloid-ß and phosphor-tau is reduced in patients with Alzheimer disease, compared to age-matched controls.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [70] de Leon MJ, Cerebrospinal Fluid Clearance in Alzheimer Disease Measured with Dynamic PET. Journal of nuclear medicine: official publication, Society of Nuclear Medicine 58, 1471– 1476 (2017). PMC5577629 28302766 source
Not checked in the free run.
- Interpretationreasoning
Reduced glymphatic clearance is predicted to increase the risk of protein aggregation because of locally stagnant fluid flow together with elevated extracellular concentration of the protein of interest.
“Reduced glymphatic clearance might then be predicted to increase the risk of protein aggregation, given the combination of locally stagnant fluid flow together with the elevated extracellular concentration of the protein of interest.”
Quote in the paperSubstantial claim- Rests on an assumption: For brain homeostasis, protein clearance must approximately equal protein synthesis.
- Premisecitation
Once a seed is formed, aggregates attract monomers of the same protein and other proteins that may be preferentially bound and entrapped.
“Once a seed is formed, the aggregates attract monomers of the same protein, as well as other proteins which may be preferentially bound and entrapped (60).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [60] Soto C, Pritzkow S, Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases. Nature neuroscience 21, 1332– 1340 (2018). 30250260 PMC6432913 source
Not checked in the free run.
- Premisecitation
Suppression of glymphatic flow by deletion of AQP4 sharply increased amyloid-β plaque formation and cognitive deficits in a mouse model of Alzheimer disease.
“the suppression of glymphatic flow by deletion of AQP4 water channels sharply increased both amyloid-ß plaque formation and cognitive deficits in a mouse model of Alzheimer disease (69).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [69] Xu Z, Deletion of aquaporin-4 in APP/PS1 mice exacerbates brain Abeta accumulation and memory deficits. Molecular neurodegeneration 10, 58 (2015). 26526066 PMC4631089 source
Not checked in the free run.
- Premisecitation
Protein self-assembly and aggregation depend on structure, concentration, ionic strength, local pH, and interactions with nucleating interfaces such as phospholipid membranes.
“Proteins self-assemble and aggregate depending upon a number of factors, among which are structure, concentration, ionic strength and local pH, as well as their interactions with nucleating interfaces, such as phospholipid membranes (61, 62).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [61] Burke KA, Yates EA, Legleiter J, Biophysical insights into how surfaces, including lipid membranes, modulate protein aggregation related to neurodegeneration. Frontiers in neurology 4, 17 (2013). 23459674 PMC3585431 source
Not checked in the free run.
- cites [62] Yates EA, Specific domains of Abeta facilitate aggregation on and association with lipid bilayers. Journal of molecular biology 425, 1915– 1933 (2013). 23524134 source
Not checked in the free run.
- Interpretationcitation
The suppression of CSF efflux in Alzheimer disease is substantial enough that it can possibly serve as a biomarker.
“The suppression of CSF in Alzheimer disease is so substantial that it can possible serve as a biomarker (70).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [70] de Leon MJ, Cerebrospinal Fluid Clearance in Alzheimer Disease Measured with Dynamic PET. Journal of nuclear medicine: official publication, Society of Nuclear Medicine 58, 1471– 1476 (2017). PMC5577629 28302766 source
Not checked in the free run.
- Premisecitation
In initial stages of Alzheimer disease, phosphorylated tau deposits in entorhinal cortex, followed by hippocampus and dorsal thalamus, with neocortex involved later.
“In the initial stages of AD, phosphorylated tau deposits in the entorhinal cortex, followed by the hippocampus and dorsal thalamus, while the neocortex becomes involved later.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [71] Hong S, Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science 352, 712– 716 (2016). 27033548 PMC5094372 source
Not checked in the free run.
- cites [72] Terada T, In vivo direct relation of tau pathology with neuroinflammation in early Alzheimer’s disease. Journal of neurology 266, 2186– 2196 (2019). 31139959 source
Not checked in the free run.
- Premisecitation
In Parkinson's disease and Lewy body disease, α-synuclein aggregates initially spread through brainstem and olfactory bulb, followed by limbic structures, and only then to neocortex.
“In Parkinson’s disease and Lewy body disease, α-synuclein aggregates initially spread through the brainstem and olfactory bulb followed by limbic structures, and only thence to the neocortex.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [67] Jucker M, Walker LC, Self-propagation of pathogenic protein aggregates in neurodegenerative diseases. Nature 501, 45– 51 (2013). 24005412 PMC3963807 source
Not checked in the free run.
- cites [73] Brundin P, Melki R, Kopito R, Prion-like transmission of protein aggregates in neurodegenerative diseases. Nature reviews. Molecular cell biology 11, 301– 307 (2010). 20308987 PMC2892479 source
Not checked in the free run.
- Premisecitation
Contrast agent remains trapped in the same brain regions for prolonged periods, especially if underlying pathology is present.
“The contrast agent remains trapped in the same regions for prolonged periods of time, especially if an underlying pathology is present (74, 75).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [74] Ringstad G, Brain-wide glymphatic enhancement and clearance in humans assessed with MRI. JCI insight 3, (2018). PMC6124518 29997300 source
Not checked in the free run.
- cites [75] Ringstad G, Vatnehol SAS, Eide PK, Glymphatic MRI in idiopathic normal pressure hydrocephalus. Brain: a journal of neurology 140, 2691– 2705 (2017). 28969373 PMC5841149 source
Not checked in the free run.
- Premisereasoning
In these neurodegenerative diseases, aggregates initially deposit at the ventral base of the forebrain and midbrain and then extend rostrally and dorsally to the cortex.
“In each of these cases, the aggregates initially deposit at the ventral base of the forebrain and midbrain, and then extend rostrally and dorsally to the cortex.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [67] Jucker M, Walker LC, Self-propagation of pathogenic protein aggregates in neurodegenerative diseases. Nature 501, 45– 51 (2013). 24005412 PMC3963807 source
Not checked in the free run.
- cites [73] Brundin P, Melki R, Kopito R, Prion-like transmission of protein aggregates in neurodegenerative diseases. Nature reviews. Molecular cell biology 11, 301– 307 (2010). 20308987 PMC2892479 source
Not checked in the free run.
- Premisecitation
Cognitive decline in Alzheimer disease correlates more closely with later-occurring tauopathy and microglial activation than with earlier amyloid-β plaque formation.
“Yet the cognitive decline of Alzheimer disease correlates more closely with the later-occurring tauopathy and microglial activation, than with the earlier amyloid-ß plaque formation (71, 72).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [71] Hong S, Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science 352, 712– 716 (2016). 27033548 PMC5094372 source
Not checked in the free run.
- cites [72] Terada T, In vivo direct relation of tau pathology with neuroinflammation in early Alzheimer’s disease. Journal of neurology 266, 2186– 2196 (2019). 31139959 source
Not checked in the free run.
- Interpretationcitation
Accumulation of low molecular weight CSF contrast agents (<1 kDa) supports the notion that much larger proteins also get trapped in tortuous extracellular spaces of deep brain regions.
“The accumulation of low molecular weight CSF contrast agents (< 1 kDa) supports the notion that much larger proteins also get trapped in the tortuous extracellular spaces of deep brain regions.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [74] Ringstad G, Brain-wide glymphatic enhancement and clearance in humans assessed with MRI. JCI insight 3, (2018). PMC6124518 29997300 source
Not checked in the free run.
- cites [75] Ringstad G, Vatnehol SAS, Eide PK, Glymphatic MRI in idiopathic normal pressure hydrocephalus. Brain: a journal of neurology 140, 2691– 2705 (2017). 28969373 PMC5841149 source
Not checked in the free run.
- Premisecitation
In Parkinson disease, REM sleep disturbances often precede the onset of motor symptoms by several years, even decades.
“in which REM sleep disturbances often precede the onset of motor symptoms by several years, even decades (80, 81).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [80] Malhotra RK, Neurodegenerative Disorders and Sleep. Sleep medicine clinics 13, 63– 70 (2018). 29412984 source
Not checked in the free run.
- cites [81] Malkani R, Attarian H, Sleep in Neurodegenerative Disorders. Current sleep medicine reports 1, 81– 90 (2015). source
Not checked in the free run.
- Interpretationreasoning
The geographic pattern of macroscopic aggregate formation closely resembles that of entrapped CSF contrast agents during challenge of glymphatic flow.
“In fact, the geographic pattern of macroscopic aggregate formation closely resembles that of entrapped CSF contrast agents during challenge of glymphatic flow in those brains (Fig. 3B).”
Quote in the paperSubstantial claim - Interpretationreasoning
The geographic spread of aggregates in Alzheimer and Parkinson diseases clearly mirrors the pattern of glymphatic inflow in the human brain as mapped by MRI.
“the geographic spread of aggregates in Alzheimer and Parkinson diseases clearly mirrors the pattern of glymphatic inflow in the human brain, as mapped by MRI.”
Quote in the paperSubstantial claim - Interpretationreasoning
Regional variations in the path of seeding across neurodegenerative diseases may reflect region- and patient-specific variability in rates of neuronal production of amyloid, tau, and α-synuclein.
“As such, the regional variations in the path of seeding noted across the different types of neurodegenerative diseases may reflect region- and patient-specific variability in the rates of neuronal production of amyloid, tau, and α-synuclein.”
Quote in the paperNot a substantial claim - Premisecitation
The most significant risk factor for developing protein aggregation, as for developing dementia, is age.
“The most significant risk factor for developing protein aggregation – just as it is for developing dementia - is age (78).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [78] Hoyer S, Age as risk factor for sporadic dementia of the Alzheimer type? Annals of the New York Academy of Sciences 719, 248– 256 (1994). 8010597 source
Not checked in the free run.
- Interpretationreasoning
Trapping of aggregation-prone proteins in the extracellular space, rather than synaptic connectivity, is responsible for the patterns of protein spread in at least some proteinopathies.
“On that basis, we propose that trapping of aggregation-prone proteins in the extracellular space, rather that synaptic connectivity, is responsible for the patterns of protein spread in at least some proteinopathies.”
Quote in the paperSubstantial claim - Premisecitation
Sampling of CSF and extracellular fluid has documented that amyloid-β, tau, and α-synuclein are present outside the cytosol.
“Sampling of CSF and extracellular fluid have documented that amyloid-ß, tau and a-synuclein are all present outside the cytosol.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [76] Davis AA, Leyns CEG, Holtzman DM, Intercellular Spread of Protein Aggregates in Neurodegenerative Disease. Annual review of cell and developmental biology 34, 545– 568 (2018). PMC6350082 30044648 source
Not checked in the free run.
- Interpretationreasoning
Age-related impairment in sleep quality may be causally involved in the increased incidence and accelerated course of neurodegenerative disease in the elderly, by diminishing clearance of brain fluid and protein waste and leading to stagnant interstitial flow that favors aggregate formation.
“The age-related impairment in sleep quality may thus be causally involved in the increased incidence and accelerated course of neurodegenerative disease in the elderly, whose disrupted sleep architecture and depth may sharply diminish the clearance of brain fluid and its attendant export of protein waste, leading in turn to the stagnant interstitial flow that favors aggregate formation.”
Quote in the paperSubstantial claim - Premisecitation
Neurodegenerative diseases including Alzheimer disease, Parkinson disease, Huntington disease, multisystem atrophies, and frontotemporal dementias are all associated with sleep disturbances.
“the neurodegenerative diseases, including Alzheimer disease, Parkinson disease, Huntington disease, the multisystem atrophies, and the frontotemporal dementias, are all associated with sleep disturbances (80).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [80] Malhotra RK, Neurodegenerative Disorders and Sleep. Sleep medicine clinics 13, 63– 70 (2018). 29412984 source
Not checked in the free run.
- Premisecitation
AQP4 SNPs are associated with the rate of cognitive decline in longitudinally followed cohorts of Alzheimer disease patients.
“Yet AQP4 SNPs have also been associated with the rate of cognitive decline in longitudinally-followed cohorts of AD patients (84).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [84] Zeppenfeld DM, Association of Perivascular Localization of Aquaporin-4 With Cognition and Alzheimer Disease in Aging Brains. JAMA neurology 74, 91– 99 (2017). 27893874 source
Not checked in the free run.
- Premisecitation
Polarized expression of AQP4 in astrocytic vascular endfeet facilitates glymphatic fluid transport and amyloid-β export in rodents.
“The polarized expression of the water channel, AQP4, in the vascular endfeet of astrocytes facilitates glymphatic fluid transport and amyloid-ß export in rodents (24, 30)(Fig. 1).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [24] Iliff JJ, A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid beta. Science translational medicine 4, 147ra 111 (2012). PMC3551275 22896675 source
Not checked in the free run.
- cites [30] Mestre H, Aquaporin-4-dependent glymphatic solute transport in the rodent brain. eLife 7, (2018). PMC6307855 30561329 source
Not checked in the free run.
- Premisecitation
Poor cardiovascular health negatively affects cognitive abilities.
“It has been known for decades that poor cardiovascular health negatively affects cognitive abilities (87, 88)”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [87] Knopman D, Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology 56, 42– 48 (2001). 11148234 source
Not checked in the free run.
- cites [88] Leritz EC, McGlinchey RE, Kellison I, Rudolph JL, Milberg WP, Cardiovascular Disease Risk Factors and Cognition in the Elderly. Curr Cardiovasc Risk Rep 5, 407– 412 (2011). 22199992 PMC3245189 source
Not checked in the free run.
- Premisecitation
Deletion of AQP4 accelerated amyloid plaque formation in a murine model of Alzheimer disease.
“Indeed, a recent study reported that deletion of AQP4 accelerated amyloid plaque formation in a murine model of Alzheimer disease (69).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [69] Xu Z, Deletion of aquaporin-4 in APP/PS1 mice exacerbates brain Abeta accumulation and memory deficits. Molecular neurodegeneration 10, 58 (2015). 26526066 PMC4631089 source
Not checked in the free run.
- Premisecitation
Expression of a cluster of transcripts encoding proteins associated with astrocytic end-feet predicted lower levels of cortical phospho-tau in human subjects.
“Similarly, the expression of a cluster of transcripts encoding proteins associated with astrocytic end-feet predicted lower levels of cortical phospho-tau in human subjects (86).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [86] Simon MJ, Transcriptional network analysis of human astrocytic endfoot genes reveals region-specific associations with dementia status and tau pathology. Scientific reports 8, 12389 (2018). 30120299 PMC6098119 source
Not checked in the free run.
- Premisecitation
A common single nucleotide polymorphism of AQP4 is linked to changes in slow wave activity during NREM sleep, mirrored by changes in daytime sleepiness and altered reaction times during extended wakefulness.
“The study demonstrating that a common single nucleotide polymorphism (SNP) of AQP4 was linked to changes in slow wave activity during NREM sleep, that were mirrored by changes in daytime sleepiness as well as in altered reaction times during extended wakefulness (83).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [83] Ulv Larsen SM, Haplotype of the astrocytic water channel AQP4 is associated with slow wave energy regulation in human NREM sleep. PLoS biology 18, e3000623 (2020). 32369477 PMC7199924 source
Not checked in the free run.
- Premisecitation
SVD is linked to glymphatic dysfunction in experimental models.
“SVD is linked glymphatic dysfunction in experimental models (91)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [91] Mortensen KN, Impaired Glymphatic Transport in Spontaneously Hypertensive Rats. The Journal of neuroscience: the official journal of the Society for Neuroscience 39, 6365– 6377 (2019). 31209176 PMC6687896 source
Not checked in the free run.
- Premisecitation
Pulsatility of penetrating arteries supplements brain motion and drives CSF into the neuropil along periarterial spaces.
“The motion of the brain is locally supplemented by the pulsatility of the penetrating arteries, as they enter the brain from the CSF-filled subarachnoid space, thereby driving CSF into the neuropil along the periarteral spaces (24).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [24] Iliff JJ, A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid beta. Science translational medicine 4, 147ra 111 (2012). PMC3551275 22896675 source
Not checked in the free run.
- Premisecitation
Stiffening of perivascular glycocalyx in diabetic patients similarly reduces convective perivascular flow.
“The stiffening of perivascular glycocalyx of diabetic patients accomplishes much the same (101)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [101] Jiang Q, Impairment of the glymphatic system after diabetes. Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism 37, 1326– 1337 (2017). PMC5453454 27306755 source
Not checked in the free run.
- Premisecitation
Glymphatic function is suppressed in hypertensive rats.
“It has been shown that glymphatic function is suppressed in hypertensive rats (91, 92).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [91] Mortensen KN, Impaired Glymphatic Transport in Spontaneously Hypertensive Rats. The Journal of neuroscience: the official journal of the Society for Neuroscience 39, 6365– 6377 (2019). 31209176 PMC6687896 source
Not checked in the free run.
- cites [92] Xue Y, Concomitant enlargement of perivascular spaces and decrease in glymphatic transport in an animal model of cerebral small vessel disease. Brain research bulletin 161, 78– 83 (2020). 32353396 source
Not checked in the free run.
- Premisecitation
As ejected blood transits arteries, it enlarges arterial diameter as the pulse wave propagates downstream.
“As the ejected blood transits the arteries, it enlarges the arterial diameter as its pulse wave propagates downstream (28).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [28] Mestre H, Flow of cerebrospinal fluid is driven by arterial pulsations and is reduced in hypertension. Nature communications 9, 4878 (2018). PMC6242982 30451853 source
Not checked in the free run.
- Interpretationreasoning
The cardiovascular system plays a previously unappreciated role in clearing neurotoxic wastes from the brain, beyond delivering energy metabolites.
“We also propose that a healthy cardiovascular system, besides its role in delivering energy metabolites to the brain, plays a hitherto-unappreciated role in the clearance of neurotoxic wastes from the brain.”
Quote in the paperSubstantial claim - Premisecitation
The brain's fluid transport system uses cardiac pulsatility to drive CSF transport in the neuropil.
“In particular, we have found that the brain’s fluid transport system is designed to take advantage of cardiac pulsatility to drive CSF transport in the neuropil (28).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [28] Mestre H, Flow of cerebrospinal fluid is driven by arterial pulsations and is reduced in hypertension. Nature communications 9, 4878 (2018). PMC6242982 30451853 source
Not checked in the free run.
- Rests on an assumption: The ejection pressure of blood from the left ventricle is partly absorbed by the elastic arterial wall of the aorta.
- Rests on an assumption: Pulsatility in large caliber arteries transmits pressure waves along the axis of major vessels and through soft brain tissue.
- Interpretationreasoning
Heart disease with reduced cardiac output (e.g., congestive heart failure, atrial dysrhythmias) is associated with diminished glymphatic flow because reduced cerebral artery pulsatility lowers driving forces.
“It should not be surprising that heart disease associated with reduced cardiac output, including such common entities as congestive heart failure and atrial dysrhythmias (95), are associated with diminished glymphatic flow, since the pulsatility of the cerebral arteries and hence the driving forces within the glymphatic system arereduced.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [95] Vogels RL, Profile of cognitive impairment in chronic heart failure. Journal of the American Geriatrics Society 55, 1764– 1770 (2007). 17727641 source
Not checked in the free run.
- Rests on an assumption: The ejection pressure of blood from the left ventricle is partly absorbed by the elastic arterial wall of the aorta.
- Rests on an assumption: Pulsatility in large caliber arteries transmits pressure waves along the axis of major vessels and through soft brain tissue.
- Premisecitation
PET imaging showed a single night of sleep deprivation significantly increases Amyloid-β burden in hippocampus and thalamus.
“Indeed, PET imaging showed that a single night of sleep deprivation resulted in a significant increase in Amyloid-β burden in the hippocampus and thalamus (109).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [109] Shokri-Kojori E, beta-Amyloid accumulation in the human brain after one night of sleep deprivation. Proceedings of the National Academy of Sciences of the United States of America 115, 4483– 4488 (2018). 29632177 PMC5924922 source
Not checked in the free run.
- Premisecitation
Clinical distinctions between Alzheimer's and vascular dementias are often blurred by frequent co-association.
“It is no wonder then that the clinical distinctions between Alzheimer’s and the vascular dementias often is blurred by their frequent co-association (102).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [102] Sweeney MD, Vascular dysfunction-The disregarded partner of Alzheimer’s disease. Alzheimer’s & dementia: the journal of the Alzheimer’s Association 15, 158– 167 (2019). PMC6338083 30642436 source
Not checked in the free run.
- Interpretationreasoning
Neurodegenerative dementias may be viewed as products of a final common pathway integrating dysfunction of these interdependent upstream mechanisms.
“The neurodegenerative dementias may thus be viewed as the products of a final common pathway that integrates the dysfunction of any and all of these closely interdependent upstream mechanisms (Fig. 3B).”
Quote in the paperNot a substantial claim - Interpretationreasoning
Observations suggest a causal link between the sleep-wake cycle and regulation of fluid flow via glymphatics, modulating the balance between protein clearance and aggregation.
“Together, these observations suggest a causal linkage between the sleep-wake cycle and its regulation of fluid flow via the glymphatics, and the modulation thereby of the balance between protein clearance and aggregation.”
Quote in the paperSubstantial claim - Interpretationreasoning
These observations suggest a basis for increased incidence of aggregation-related disorders with aging, tracking age-related declines in vascular health and glymphatic patency.
“As such, they suggest a basis for the increased incidence of aggregation-related disorders seen with aging, the appearance of which tracks age-related declines in both vascular health and glymphatic patency.”
Quote in the paperSubstantial claim - Interpretationcitation
SVD may potentiate progression of neurodegenerative dementias in patients at risk for SVD-associated vascular dementia.
“SVD is linked glymphatic dysfunction in experimental models (91), and may potentiate the progression of neurodegenerative dementias in precisely the same patients at risk for SVD-associated vascular dementia.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [91] Mortensen KN, Impaired Glymphatic Transport in Spontaneously Hypertensive Rats. The Journal of neuroscience: the official journal of the Society for Neuroscience 39, 6365– 6377 (2019). 31209176 PMC6687896 source
Not checked in the free run.
- May combine two claims. 52
- Classified as probably not a substantial claim. 12
May combine two claims.
PremisecitationSleep quality declines with age, and disrupted sleep architecture frequently precedes dementia onset in neurodegenerative diseases.
“The quality of sleep decreases as we age and disruption of the regular sleep architecture is a frequent antecedent to the onset of dementia in neurodegenerative diseases.”
- Also stated in: § Sleep, aging, neurodegeneration and the glymphatic system · plain
“Most NREM sleep in people over 60 years is light, consisting of the more superficial stages 1–2 (79)”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [79] Landolt HP, Borbely AA, Age-dependent changes in sleep EEG topography. Clinical neurophysiology: official journal of the International Federation of Clinical Neurophysiology 112, 369– 377 (2001). 11165543 source
Not checked in the free run.
- cites [80] Malhotra RK, Neurodegenerative Disorders and Sleep. Sleep medicine clinics 13, 63– 70 (2018). 29412984 source
Not checked in the free run.
- Also stated in: § Sleep, aging, neurodegeneration and the glymphatic system · plain
May combine two claims.
PremisecitationThe glymphatic system is a cerebrospinal fluid transport system that shares functions with peripheral lymphatic vessels, including export of excess interstitial fluid and proteins.
“The glymphatic system is a highly organized cerebrospinal fluid transport system that shares several key functions with the lymphatic vessels of peripheral tissues, including the export of excess interstitial fluid and proteins”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [24] Iliff JJ, A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid beta. Science translational medicine 4, 147ra 111 (2012). PMC3551275 22896675 source
Not checked in the free run.
- Rests on an assumption: For brain homeostasis, protein clearance must approximately equal protein synthesis.
May combine two claims.
PremisecitationBrain fluid clearance occurs through glymphatic perivascular spaces formed by astrocytic vascular endfeet, because the brain lacks histologically distinct lymphatic vessels.
“Yet brain tissue itself lacks histologically-distinct lymphatic vessels. Rather, fluid clearance from the brain proceeds via the glymphatics, a structurally distinct system of fluid transport that utilizes the perivascular spaces created by the vascular endfeet of astrocytes (26).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [26] Simard M, Arcuino G, Takano T, Liu QS, Nedergaard M, Signaling at the gliovascular interface. The Journal of neuroscience: the official journal of the Society for Neuroscience 23, 9254– 9262 (2003). 14534260 PMC6740832 source
Not checked in the free run.
May combine two claims.
PremisecitationThe glymphatic system clears protein waste from the brain and is mostly active during sleep.
“The glymphatic system, which clears the brain of protein waste products, is mostly active during sleep.”
- Also stated in: § The glymphatic and lymphatic systems · plain
“fluid transport is enabled by sleep and suppressed during wakefulness”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [35] Xie L, Sleep drives metabolite clearance from the adult brain. Science 342, 373– 377 (2013). 24136970 PMC3880190 source
Not checked in the free run.
- cites [36] Hablitz LM, Increased glymphatic influx is correlated with high EEG delta power and low heart rate in mice under anesthesia. Sci Adv 5, eaav5447 (2019). 30820460 PMC6392807 source
Not checked in the free run.
- Rests on an assumption: For brain homeostasis, protein clearance must approximately equal protein synthesis.
- Also stated in: § The glymphatic and lymphatic systems · plain
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationSleep deprivation increases EEG slow wave activity during recovery sleep.
“the antecedent sleep loss can be identified post hoc by an increase in EEG slow wave activity during recovery sleep (8)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [8] Rodriguez AV, Why Does Sleep Slow-Wave Activity Increase After Extended Wake? Assessing the Effects of Increased Cortical Firing During Wake and Sleep. The Journal of neuroscience: the official journal of the Society for Neuroscience 36, 12436– 12447 (2016). 27927960 PMC5148229 source
Not checked in the free run.
May combine two claims.
PremisecitationGlymphatic clearance is enabled by sleep and suppressed during wakefulness.
“glymphatic clearance is temporally regulated and cyclically so, in that fluid transport is enabled by sleep and suppressed during wakefulness.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [35] Xie L, Sleep drives metabolite clearance from the adult brain. Science 342, 373– 377 (2013). 24136970 PMC3880190 source
Not checked in the free run.
- cites [36] Hablitz LM, Increased glymphatic influx is correlated with high EEG delta power and low heart rate in mice under anesthesia. Sci Adv 5, eaav5447 (2019). 30820460 PMC6392807 source
Not checked in the free run.
May combine two claims.
InterpretationreasoningWaste removal is likely most efficient in the early hours of sleep and especially during recovery sleep after prolonged wakefulness.
“As such, waste removal is likely most efficient in the early hours of sleep, and especially during recovery sleep after prolonged wakefulness (37).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [37] Hauglund L, Pavan C, Nedergaard M, Cleaning the sleeping brain – the potential restorative function of the glymphatic system. Current Opinion in Physiology 15 1– 6 (2020). source
Not checked in the free run.
May combine two claims.
PremisecitationThe circadian rhythm of glymphatic flow is supported by temporally regulated AQP4 localization via the dystrophin-associated complex, linking to the molecular circadian clock.
“This rhythm is supported by the temporally-regulated localization of AQP4 via the dystrophin associated complex, providing a dynamic link to the molecular circadian clock (38),”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [38] Hablitz L, Circadian control of brain glymphatic/lymphatic fluid flow. Nature communications (in press), (2020). PMC7468152 32879313 source
Not checked in the free run.
May combine two claims.
PremisecitationAstrocytic endfeet are connected by gap junctions, and about half of their plasma membrane facing the vessel wall contains AQP4 square arrays.
“The astrocytic endfeet are connected by gap junctions, and almost 50% of their plasma membrane facing the vessel wall is occupied by square arrays composed of the water channel AQP4 (29).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [29] Nagelhus EA, Ottersen OP, Physiological roles of aquaporin-4 in brain. Physiological reviews 93, 1543– 1562 (2013). 24137016 PMC3858210 source
Not checked in the free run.
May combine two claims.
PremisecitationDeletion of AQP4 reduces CSF tracer influx and solute efflux from the neuropil.
“Deletion of AQP4 channels reduces both the influx of CSF tracers and the efflux of solutes from the neuropil (24, 30, 31).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [24] Iliff JJ, A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid beta. Science translational medicine 4, 147ra 111 (2012). PMC3551275 22896675 source
Not checked in the free run.
- cites [30] Mestre H, Aquaporin-4-dependent glymphatic solute transport in the rodent brain. eLife 7, (2018). PMC6307855 30561329 source
Not checked in the free run.
- cites [31] Mestre H, Cerebrospinal fluid influx drives acute ischemic tissue swelling. Science 367, (2020). PMC7375109 32001524 source
Not checked in the free run.
May combine two claims.
PremisecitationGlymphatic fluid transport is directionally polarized: influx along penetrating arteries, AQP4-supported entry into neuropil, and efflux along peri-venous spaces and cranial and spinal nerves.
“fluid transport through the glymphatic system is directionally polarized, with influx along penetrating arteries, fluid entry into the neuropil supported by AQP4, and efflux along the peri-venous spaces, as well as along the cranial and spinal nerves (24, 32–34).”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [24] Iliff JJ, A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid beta. Science translational medicine 4, 147ra 111 (2012). PMC3551275 22896675 source
Not checked in the free run.
- cites [32] Braun M, Iliff JJ, The impact of neurovascular, blood-brain barrier, and glymphatic dysfunction in neurodegenerative and metabolic diseases. International review of neurobiology 154, 413– 436 (2020). 32739013 source
Not checked in the free run.
- cites [33] Wang X, An ocular glymphatic clearance system removes beta-amyloid from the rodent eye. Science translational medicine 12, (2020). PMC7356596 32213628 source
Not checked in the free run.
- cites [34] Mestre H, Mori Y, Nedergaard M, The Brain’s Glymphatic System: Current Controversies. Trends in neurosciences, (2020). PMC7331945 32423764 source
Not checked in the free run.
May combine two claims.
PremisecitationBrain fluid transport initiates and proceeds during NREM sleep, and CSF tracer influx correlates with EEG slow wave activity prevalence.
“Brain fluid transport initiates and proceeds during NREM sleep, and CSF tracer influx correlates with the prevalence of EEG slow wave activity (35, 36).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [35] Xie L, Sleep drives metabolite clearance from the adult brain. Science 342, 373– 377 (2013). 24136970 PMC3880190 source
Not checked in the free run.
- cites [36] Hablitz LM, Increased glymphatic influx is correlated with high EEG delta power and low heart rate in mice under anesthesia. Sci Adv 5, eaav5447 (2019). 30820460 PMC6392807 source
Not checked in the free run.
May combine two claims.
PremisecitationGlymphatic flow is regulated by circadian rhythmicity, peaking during the sleep phase of diurnal activity and falling during the active phase, independent of the light cycle.
“A recent analysis showed that glymphatic flow is also regulated by circadian rhythmicity, such that fluid transport peaks during the sleep phase of diurnal activity, and falls during the active phase, independent of the light cycle.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [38] Hablitz L, Circadian control of brain glymphatic/lymphatic fluid flow. Nature communications (in press), (2020). PMC7468152 32879313 source
Not checked in the free run.
May combine two claims.
PremisecitationUV photoablation of meningeal lymphatic vessels and mechanical ligation of cervical lymphatics aggravated amyloid plaque formation in mouse models of Alzheimer disease.
“Conversely, both UV photoablation of meningeal lymphatic vessels and mechanical ligation of cervical lymphatics aggravated amyloid plaque formation in the same mouse models of Alzheimer disease (50, 51).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [50] Da Mesquita S, Functional aspects of meningeal lymphatics in ageing and Alzheimer’s disease. Nature 560, 185– 191 (2018). 30046111 PMC6085146 source
Not checked in the free run.
- cites [51] Wang L, Deep cervical lymph node ligation aggravates AD-like pathology of APP/PS1 mice. Brain pathology 29, 176– 192 (2019). 30192999 PMC8028636 source
Not checked in the free run.
May combine two claims.
PremisecitationVEGFC overexpression induced sprouting of meningeal lymphatic vessels and slowed cognitive decline in a mouse model of Alzheimer disease.
“VEGFC-overexpression induced spouting of the meningeal lymphatic vessels and slowed the cognitive decline in a mouse model of Alzheimer disease (50).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [50] Da Mesquita S, Functional aspects of meningeal lymphatics in ageing and Alzheimer’s disease. Nature 560, 185– 191 (2018). 30046111 PMC6085146 source
Not checked in the free run.
May combine two claims.
PremisecitationThe glymphatic and meningeal lymphatic systems are connected, and CSF tracers exit the CNS via meningeal lymphatic vessels, especially ventral lymph vessels draining to cervical lymph nodes.
“Yet the glymphatic and meningeal lymphatic systems are clearly connected: CSF tracers can exit the CNS via the meningeal lymphatic vessels, particularly by way of the lymph vessels draining the ventral aspect of the brain draining to the cervical lymph nodes (39, 40, 42).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [39] Louveau A, Structural and functional features of central nervous system lymphatic vessels. Nature 523, 337– 341 (2015). 26030524 PMC4506234 source
Not checked in the free run.
- cites [40] Aspelund A, A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules. The Journal of experimental medicine 212, 991– 999 (2015). 26077718 PMC4493418 source
Not checked in the free run.
- cites [42] Ahn JH, Meningeal lymphatic vessels at the skull base drain cerebrospinal fluid. Nature 572, 62– 66 (2019). 31341278 source
Not checked in the free run.
May combine two claims.
PremisecitationIn a murine Alzheimer disease model, amyloid-β is present at high concentrations in cervical and axillary lymph nodes, at levels analogous to brain, and is undetectable or barely detectable in spleen and other peripheral tissues.
“in a murine model of Alzheimer disease, amyloid-b was present in high concentrations in the cervical and axillary lymph nodes, at levels analogous to those in the brain, and yet was either undetectable or barely so in the spleen and other peripheral tissues (47).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [47] Pappolla M, Evidence for lymphatic Abeta clearance in Alzheimer’s transgenic mice. Neurobiology of disease 71, 215– 219 (2014). 25102344 PMC5589075 source
Not checked in the free run.
May combine two claims.
PremisecitationCSF exit via meningeal lymph vessels and cranial and spinal nerve roots is rapid, with contrast agents detected in deep cervical lymph nodes within minutes after CSF delivery.
“CSF exit from the CNS by way of the meningeal lymph vessels, as well as via both cranial and spinal nerve roots, is rapid; contrast agents can be detected in the deep cervical lymph nodes within minutes after CSF delivery (42–45).”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [42] Ahn JH, Meningeal lymphatic vessels at the skull base drain cerebrospinal fluid. Nature 572, 62– 66 (2019). 31341278 source
Not checked in the free run.
- cites [43] Ma Q, Rapid lymphatic efflux limits cerebrospinal fluid flow to the brain. Acta neuropathologica 137, 151– 165 (2019). 30306266 PMC6338719 source
Not checked in the free run.
- cites [44] Ma Q, Decker Y, Muller A, Ineichen BV, Proulx ST, Clearance of cerebrospinal fluid from the sacral spine through lymphatic vessels. The Journal of experimental medicine 216, 2492– 2502 (2019). 31455602 PMC6829589 source
Not checked in the free run.
- cites [45] Jacob L, Anatomy and function of the vertebral column lymphatic network in mice. Nature communications 10, 4594 (2019). PMC6785564 31597914 source
Not checked in the free run.
May combine two claims.
PremisecitationGlymphatic CSF influx and CSF clearance are reduced in early amyloid deposition in the APP/PS1 Alzheimer disease model compared with littermate controls, and CSF clearance continues to decline as amyloid burden increases.
“glymphatic CSF influx and CSF clearance are each reduced in early stages of amyloid deposition in the APP/PS1 model of Alzheimer disease, compared with littermate controls; CSF clearance continues to decline as the amyloid burden increases (Fig. 1b).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [50] Da Mesquita S, Functional aspects of meningeal lymphatics in ageing and Alzheimer’s disease. Nature 560, 185– 191 (2018). 30046111 PMC6085146 source
Not checked in the free run.
- cites [55] Peng W, Suppression of glymphatic fluid transport in a mouse model of Alzheimer’s disease. Neurobiology of disease 93, 215– 225 (2016). 27234656 PMC4980916 source
Not checked in the free run.
May combine two claims.
PremisecitationThe suppressive effects of age and amyloid-β overexpression on glymphatic flow extend to other rodent neurodegeneration models; traumatic brain injury and Parkinson's disease are linked to sustained reduction of glymphatic fluid transport.
“The suppressive effects of both age and amyloid-ß overexpression on glymphatic flow can be extended to other experimental rodent models of neurodegeneration; both traumatic brain injury and Parkinson’s disease are similarly linked to a sustained reduction of glymphatic fluid transport (56–58).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [56] Iliff JJ, Impairment of glymphatic pathway function promotes tau pathology after traumatic brain injury. The Journal of neuroscience: the official journal of the Society for Neuroscience 34, 16180– 16193 (2014). 25471560 PMC4252540 source
Not checked in the free run.
- cites [57] Zou W, Blocking meningeal lymphatic drainage aggravates Parkinson’s disease-like pathology in mice overexpressing mutated alpha-synuclein. Translational neurodegeneration 8, 7 (2019). 30867902 PMC6396507 source
Not checked in the free run.
- cites [58] Sundaram S, Establishing a framework for neuropathological correlates and glymphatic system functioning in Parkinson’s disease. Neuroscience and biobehavioral reviews 103, 305– 315(2019). 31132378 PMC6692229 source
Not checked in the free run.
May combine two claims.
PremisecitationThe decrease in glymphatic flow in old mice is partly mediated by mislocation of AQP4 away from the vascular wall and possibly by atrophy of meningeal lymphatic vessels.
“The decrease in glymphatic flow in old mice is in part mediated by mislocation of AQP4 water channels away from the vascular wall (52) and possible by atrophy of meningeal lymphatic vessel (42).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [52] Kress BT, Impairment of paravascular clearance pathways in the aging brain. Annals of neurology 76, 845– 861 (2014). 25204284 PMC4245362 source
Not checked in the free run.
- cites [42] Ahn JH, Meningeal lymphatic vessels at the skull base drain cerebrospinal fluid. Nature 572, 62– 66 (2019). 31341278 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe hallmark feature of proteinopathies is fibrillary aggregates of misfolded or hyperphosphorylated proteins.
“The hallmark feature of these proteinopathies are the fibrillary aggregates of misfolded or hyperphosphorylated proteins (59).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [59] Soto C, Unfolding the role of protein misfolding in neurodegenerative diseases. Nature reviews. Neuroscience 4, 49– 60 (2003). 12511861 source
Not checked in the free run.
May combine two claims.
PremisecitationAggregate spread happens in both antero- and retrograde directions across regions that are anatomical neighbors, weakening arguments for synaptic spread.
“The arguments for synaptic spread are somewhat weakened by the fact that aggregate spread happens in both antero- and retrograde directions across regions that are anatomical neighbors (68).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [68] Henderson MX, Spread of alpha-synuclein pathology through the brain connectome is modulated by selective vulnerability and predicted by network analysis. Nature neuroscience 22, 1248– 1257 (2019). 31346295 PMC6662627 source
Not checked in the free run.
Classified as probably not a substantial claim.
PremisecitationSpecific misfolded and aggregated proteins can propagate and spread in a prion-like fashion.
“The recent discovery that specific misfolded and aggregated proteins can propagate and spread in a prion-like fashion has sparked considerable interest (67).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [67] Jucker M, Walker LC, Self-propagation of pathogenic protein aggregates in neurodegenerative diseases. Nature 501, 45– 51 (2013). 24005412 PMC3963807 source
Not checked in the free run.
Probably not a substantial claim: may not pass S1 (asserted). May combine two claims.
InterpretationcitationAn alternative hypothesis is that aggregates spread via extracellular spaces, and age-dependent reduction in glymphatic flow with fluid stagnation raises local protein concentration to a level favoring aggregation.
“An alternative hypothesis is that aggregates simply spread via the extracellular spaces, and that the age-dependent reduction in glymphatic flow, with its attendant fluid stagnation, raises the local protein concentration to a level that favors aggregation.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationAggregation-prone proteins include amyloid-β in Alzheimer disease; phosphorylated tau in frontotemporal dementia, chronic traumatic encephalopathy, and Alzheimer's; α-synuclein in Parkinson's, Lewy body disease, and multisystem atrophies; mutant huntingtin in Huntington's disease; and TDP-43 in ALS and frontotemporal dementia.
“These aggregation-prone proteins include amyloid-ß in Alzheimer Disease; phosphorylated tau in frontotemporal dementia (FTD) and chronic traumatic encephalopathy, as well as in Alzheimer’s; α-synuclein in Parkinson’s, Lewy body disease, and the multisystem atrophies; mutant huntingtin in Huntington’s disease, and TDP-43 in ALS and FTD (60).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [60] Soto C, Pritzkow S, Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases. Nature neuroscience 21, 1332– 1340 (2018). 30250260 PMC6432913 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAlthough specific protein species differ across neurodegenerative disorders, in most cases their aggregates are formed in part by interactions of intermolecular β-sheet-rich strands.
“Although the specific protein species differ in the different neurodegenerative disorders, in most cases their protein aggregates are formed in part by the interactions of intermolecular β-sheet-rich strands.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [60] Soto C, Pritzkow S, Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases. Nature neuroscience 21, 1332– 1340 (2018). 30250260 PMC6432913 source
Not checked in the free run.
May combine two claims.
PremisecitationA lack of fluid flow (stagnation) or shear stress can promote aggregation, which can occur at a distance from the protein source, for example along the cerebral vasculature.
“A lack of fluid flow, i.e. stagnation, or its opposite, shear stress, can also promote aggregation (64, 65), which can occur at a distance from the protein source - for example, along the cerebral vasculature (Fig. 1) (66).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [64] Trumbore CN, Shear-Induced Amyloid Formation in the Brain: I. Potential Vascular and Parenchymal Processes. Journal of Alzheimer’s disease: JAD 54, 457– 470 (2016). 27567812 PMC5026135 source
Not checked in the free run.
- cites [65] Roeters SJ, Evidence for Intramolecular Antiparallel Beta-Sheet Structure in Alpha-Synuclein Fibrils from a Combination of Two-Dimensional Infrared Spectroscopy and Atomic Force Microscopy. Scientific reports 7, 41051 (2017). 28112214 PMC5253669 source
Not checked in the free run.
- cites [66] Weller RO, Pathology of cerebrospinal fluid and interstitial fluid of the CNS: significance for Alzheimer disease, prion disorders and multiple sclerosis. Journal of neuropathology and experimental neurology 57, 885– 894 (1998). 9786239 source
Not checked in the free run.
May combine two claims.
PremisecitationNeuroimaging studies from the Eide group show that intrathecally delivered contrast agents first enter the brain along large cerebral arteries, reaching mediobasal frontal lobe and cingulate cortex via the anterior cerebral artery, insula via the middle cerebral artery, and limbic structures including hippocampus and entorhinal cortex via the posterior circulation.
“Neuroimaging studies from the Eide group have shown that intrathecally-delivered contrast agents first are propelled into the brain along the large cerebral arteries entering the mediobasal frontal lobe and cingulate cortex along the anterior cerebral artery, insula via the middle cerebral artery and the limbic structures, including the hippocampus and entorhinal cortex via the posterior cir”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [74] Ringstad G, Brain-wide glymphatic enhancement and clearance in humans assessed with MRI. JCI insight 3, (2018). PMC6124518 29997300 source
Not checked in the free run.
- cites [75] Ringstad G, Vatnehol SAS, Eide PK, Glymphatic MRI in idiopathic normal pressure hydrocephalus. Brain: a journal of neurology 140, 2691– 2705 (2017). 28969373 PMC5841149 source
Not checked in the free run.
May combine two claims.
PremisecitationIn Alzheimer disease, amyloid-β deposition typically first occurs in basal portions of frontal, temporal, and occipital lobes, later spreads to hippocampus and posterior parietal cortex, initially sparing motor and sensory cortex, and finally recruits these regions and subcortical gray matter.
“In Alzheimer disease, amyloid-ß deposition typically first deposit in the basal portions of the frontal, temporal, and occipital lobes. Later the plaques spread to include the hippocampus and posterior parietal cortex, initially sparing both the motor and sensory cortex. These latter regions are first recruited in the final stages of the disease, along with subcortical gray matter regions.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [71] Hong S, Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science 352, 712– 716 (2016). 27033548 PMC5094372 source
Not checked in the free run.
- cites [72] Terada T, In vivo direct relation of tau pathology with neuroinflammation in early Alzheimer’s disease. Journal of neurology 266, 2186– 2196 (2019). 31139959 source
Not checked in the free run.
May combine two claims.
PremisecitationThese proteins lack N-terminal signal sequences, so unconventional mechanisms must be responsible for their release.
“These proteins all lack N-terminal signal sequences, so that unconventional mechanisms must be responsible for their release (76).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [76] Davis AA, Leyns CEG, Holtzman DM, Intercellular Spread of Protein Aggregates in Neurodegenerative Disease. Annual review of cell and developmental biology 34, 545– 568 (2018). PMC6350082 30044648 source
Not checked in the free run.
May combine two claims.
InterpretationcitationThe aged brain spends less time in NREM sleep, potentially causing a catastrophic decline in clearance of brain waste, because glymphatic fluid transport efficacy correlates directly with slow wave activity prevalence.
“Thus, the aged brain spends less time in NREM sleep, potentially causing a catastrophic decline in clearance of brain waste, as the efficacy of glymphatic fluid transport correlates directly with the prevalence of slow wave activity (36).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [36] Hablitz LM, Increased glymphatic influx is correlated with high EEG delta power and low heart rate in mice under anesthesia. Sci Adv 5, eaav5447 (2019). 30820460 PMC6392807 source
Not checked in the free run.
- cites [79] Landolt HP, Borbely AA, Age-dependent changes in sleep EEG topography. Clinical neurophysiology: official journal of the International Federation of Clinical Neurophysiology 112, 369– 377 (2001). 11165543 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationSeveral studies have highlighted the critical role of oligomers as both directly toxic and as niduses for macromolecular aggregation.
“several studies have highlighted the critical role of oligomers as both directly toxic, and as niduses for macromolecular aggregation.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [60] Soto C, Pritzkow S, Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases. Nature neuroscience 21, 1332– 1340 (2018). 30250260 PMC6432913 source
Not checked in the free run.
May combine two claims.
PremisecitationProteins involved in neurodegenerative diseases may normally be intracellular or extracellular, but all are present in the extracellular space.
“while proteins involved in neurodegenerative diseases may normally be either intracellular or extracellular in nature, all are present in the extracellular space.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [76] Davis AA, Leyns CEG, Holtzman DM, Intercellular Spread of Protein Aggregates in Neurodegenerative Disease. Annual review of cell and developmental biology 34, 545– 568 (2018). PMC6350082 30044648 source
Not checked in the free run.
May combine two claims.
PremisecitationOlder individuals rarely enter deep NREM stage 3 sleep; most NREM sleep in people over 60 years is light, consisting of superficial stages 1-2.
“Perhaps more critically, older individuals rarely enter deep NREM, stage 3 sleep. Most NREM sleep in people over 60 years is light, consisting of the more superficial stages 1–2 (79)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [79] Landolt HP, Borbely AA, Age-dependent changes in sleep EEG topography. Clinical neurophysiology: official journal of the International Federation of Clinical Neurophysiology 112, 369– 377 (2001). 11165543 source
Not checked in the free run.
May combine two claims.
PremisecitationSleep quality decreases as a function of normal aging; insomnia is more frequent with age, and total sleep duration becomes shorter and more interrupted.
“sleep quality decreases as a function of normal aging. Insomnia is more frequent with age, and total sleep duration becomes shorter and more interrupted.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [79] Landolt HP, Borbely AA, Age-dependent changes in sleep EEG topography. Clinical neurophysiology: official journal of the International Federation of Clinical Neurophysiology 112, 369– 377 (2001). 11165543 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
InterpretationcitationThe failure of immune therapies to clear amyloid-β in Alzheimer patients may reflect relatively late initiation of treatment or insufficient antibody load to clear enough amyloid-β for clinical benefit.
“The failure of these clinical trials may reflect the relatively late initiation of treatment or that the antibody load was not enough to clear sufficient amyloid-ß to yield clinical benefit.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [77] Knopman DS, Sifting through a failed Alzheimer trial: What biomarkers tell us about what happened. Neurology 90, 447– 448 (2018). 29429973 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationCardiovascular fitness positively correlates with cognition in young adults and preserves cognitive performance with aging.
“while cardiovascular fitness positively correlates with cognition in young adults (89) and preserves cognitive performance with aging (90).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [89] Aberg MAI, Cardiovascular fitness is associated with cognition in young adulthood. Proceedings of the National Academy of Sciences of the United States of America 106, 20906– 20911 (2009). 19948959 PMC2785721 source
Not checked in the free run.
- cites [90] Wendell CR, Cardiorespiratory fitness and accelerated cognitive decline with aging. J Gerontol A Biol Sci Med Sci 69, 455– 462 (2014). 24192540 PMC3968827 source
Not checked in the free run.
May combine two claims.
PremisecitationThe integrity of perivascular AQP4 localization degrades with Alzheimer disease, while it is preserved in subjects older than 85 years who remained cognitively intact.
“Structurally, the integrity of perivascular AQP4 localization was found to degrade with AD, while it was preserved by subjects older than 85 years, who remained cognitively intact (84).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [84] Zeppenfeld DM, Association of Perivascular Localization of Aquaporin-4 With Cognition and Alzheimer Disease in Aging Brains. JAMA neurology 74, 91– 99 (2017). 27893874 source
Not checked in the free run.
May combine two claims.
PremisecitationPatients with two specific AQP4 SNPs exhibited slower cognitive decline after Alzheimer disease diagnosis, while cognitive decline progressed more rapidly in subjects with two other AQP4 SNPs.
“Patients with two specific AQP4 SNPs exhibited slower cognitive decline after AD diagnosis, while conversely, cognitive decline progressed more rapidly in subjects with two other AQP4 SNPs (85).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [85] Burfeind KG, The effects of noncoding aquaporin-4 single-nucleotide polymorphisms on cognition and functional progression of Alzheimer’s disease. Alzheimer’s & dementia 3, 348– 359 (2017). PMC5651426 29067342 source
Not checked in the free run.
May combine two claims.
PremisecitationIn humans, genetic variation in AQP4 impacts both sleep and amyloid-β burden.
“In man, genetic variation in AQP4 has been shown to impact both sleep and amyloid-β burden (82).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [82] Rainey-Smith SR, Genetic variation in Aquaporin-4 moderates the relationship between sleep and brain Aβ-amyloid burden. Translational psychiatry 8, 47 (2018). 29479071 PMC5865132 source
Not checked in the free run.
May combine two claims.
InterpretationreasoningTargeting the brain's waste removal system may be an attractive approach for alleviating the waste burden of proteinopathies, because aggregation-prone proteins are removed by bulk flow without the requirement for specific transporters.
“Targeting the brain’s waste removal system may thus an attractive approach for alleviating the waste burden of the proteinopathies, because aggregation-prone proteins are removed by bulk flow, without the requirement for specific transporters.”
Quote in the paperSubstantial claim- Rests on an assumption: For brain homeostasis, protein clearance must approximately equal protein synthesis.
May combine two claims.
InterpretationcitationAlthough AQP4 is expressed only in astrocytes and not in amyloid-producing neurons, considerable evidence indicates that AQP4 modulates sleep architecture, tolerance to sleep deprivation, amyloid-β accumulation, and progression of Alzheimer disease.
“Thus, although AQP4 is expressed only in astrocytes, and not in amyloid-producing neurons, considerable evidence indicates that AQP4 modulates both sleep architecture, the tolerance to sleep deprivation, amyloid-ß accumulation, and the progression of Alzheimer disease.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationSVD is common in hypertensive patients (many also diabetic or smokers) and progresses silently for years before dementia is clinically evident.
“SVD is common in hypertensive patients, many of whom are concurrently diabetic or smokers, and it progresses silently for years before dementia is clinically evident (99).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [99] Wardlaw JM, Smith C, Dichgans M, Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging. The Lancet. Neurology 12, 483– 497 (2013). 23602162 PMC3836247 source
Not checked in the free run.
May combine two claims.
InterpretationcitationCognitive decline in patients with low cardiac ejection fraction may also reflect poor glymphatic flow and incomplete waste clearance, predisposing to aggregate formation and further slowing of glymphatic flow.
“Indeed, the cognitive decline frequently noted in patients with low cardiac ejection fraction, so often attributed to low cerebral perfusion, may also reflect poor glymphatic flow and incomplete waste clearance, as well as a consequent predisposition to aggregate formation and still-slower glymphatic flow as a result (95).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [95] Vogels RL, Profile of cognitive impairment in chronic heart failure. Journal of the American Geriatrics Society 55, 1764– 1770 (2007). 17727641 source
Not checked in the free run.
May combine two claims.
InterpretationcitationSleep quality is compromised in cardiovascular diseases, perhaps providing a link to impaired glymphatic clearance and subsequent protein aggregation and dementia.
“It is also well-establish that the quality of sleep is compromised in cardiovascular diseases (93) perhaps providing a link to impaired glymphatic clearance and subsequent protein aggregation and dementia (94).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [93] Gonzaga C, Bertolami A, Bertolami M, Amodeo C, Calhoun D, Obstructive sleep apnea, hypertension and cardiovascular diseases. Journal of human hypertension 29, 705– 712 (2015). 25761667 source
Not checked in the free run.
- cites [94] Mestre H, Kostrikov S, Mehta RI, Nedergaard M, Perivascular spaces, glymphatic dysfunction, and small vessel disease. Clinical science 131, 2257– 2274 (2017). 28798076 PMC5567781 source
Not checked in the free run.
May combine two claims.
PremisecitationSVD is a vascular disorder targeting small cerebral vessels, with progressive thickening of penetrating arteriole walls.
“Small vessel disease (SVD) is a vascular disorder that targets the small cerebral vessels, in which penetrating arterioles undergo progressive thickening of their walls (96).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [96] Wardlaw JM, Smith C, Dichgans M, Small vessel disease: mechanisms and clinical implications. The Lancet. Neurology 18, 684– 696 (2019). 31097385 source
Not checked in the free run.
May combine two claims.
PremisecitationDeterioration of the vascular bed may occur alone or with other pathologies, leading to progressive demyelination and white matter loss.
“Deterioration of the vascular bed may occur alone or in combination with other pathologies (97), leading to progressive demyelination and loss of white matter (98).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [97] Iadecola C, The pathobiology of vascular dementia. Neuron 80, 844– 866 (2013). 24267647 PMC3842016 source
Not checked in the free run.
- cites [98] Zlokovic BV, Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders. Nature reviews. Neuroscience 12, 723– 738 (2011). 22048062 PMC4036520 source
Not checked in the free run.
May combine two claims.
PremisecitationHypertension induces hypertrophy of vascular smooth muscle cells and arterial wall stiffening, dampening pulsatility and compliance, reducing convective perivascular flow.
“Hypertension in particular induces hypertrophy of vascular smooth muscle cells, with a stiffening of the arterial wall that dampens arterial wall pulsatility and compliance, thus reducing convective perivascular flow (94, 100).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [94] Mestre H, Kostrikov S, Mehta RI, Nedergaard M, Perivascular spaces, glymphatic dysfunction, and small vessel disease. Clinical science 131, 2257– 2274 (2017). 28798076 PMC5567781 source
Not checked in the free run.
- cites [100] Wardlaw JM, Perivascular spaces in the brain: anatomy, physiology and pathology. Nature reviews. Neurology 16, 137– 153 (2020). 32094487 source
Not checked in the free run.
Probably not a substantial claim: may not pass S2 (checkable). May combine two claims.
InterpretationcitationThese processes are linked by regulation of the brain's glymphatic system; directed regulation may offer therapeutic opportunities for disease-modifying treatment.
“These various processes are linked in their regulation by the brain’s glymphatic system, whose directed regulation in turn may present bold new therapeutic opportunities for the disease-modifying treatment of patients with these disorders (75).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [75] Ringstad G, Vatnehol SAS, Eide PK, Glymphatic MRI in idiopathic normal pressure hydrocephalus. Brain: a journal of neurology 140, 2691– 2705 (2017). 28969373 PMC5841149 source
Not checked in the free run.
May combine two claims.
InterpretationreasoningSleep is needed to clear proteins from brain extracellular space; failure leads to aggregation, flow impedance, further fibril polymerization, and inflammation that suppresses glymphatic flow in affected regions.
“We need sleep to clear proteins from the brain extracellular space, less they aggregate, impede flow, and in a vicious positive feedback cycle, potentiate further fibril polymerization, which together with inflammation then suppresses glymphatic flow in the most affected regions.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningThe most fundamental reason for sleep is self-preservation: only the sleeping brain can efficiently clear waste products generated during wakefulness.
“Yet the most fundamental incentive for the brain to sleep lies in its own self-preservation: Only the sleeping brain is capable of efficiently cleaning up the waste products generated during active wakefulness.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S4 (based). May combine two claims.
InterpretationreasoningHigh incidence of interstitial lung disease in resolved COVID19 patients may predict higher risk of aggregation disorders, as greater risk of long-term heart failure may predict impaired lymphatic and glymphatic flow.
“Indeed, the high incidence of interstitial lung disease that is emerging in patients with resolved COVID19 may predict a higher risk of aggregation disorders for these individuals going forward, as their greater risk of long-term heart failure may predict their impaired lymphatic and hence glymphatic flow.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S2 (checkable), S4 (based).
InterpretationreasoningModulation of glymphatic flow and protein clearance requires deeper understanding of dependence of glymphatic and lymphatic flow on intracardiac pressures.
“These systems are intimately connected, so that modulation of glymphatic flow and hence protein clearance from the brain will ultimately require a deeper understanding of the dependence of both glymphatic and lymphatic flow on intracardiac pressures.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationRecent neuroimaging advances provide approaches to map the human glymphatic system and assess its functional competence in disease and effects on sleep-dependent glymphatic cyclicity.
“In that regard, recent advances in neuroimaging have provided multiple approaches to map the human glymphatic system, and hence to assess its functional competence in the context of disease, as well as of the effects thereof on sleep-dependent glymphatic cyclicity (72, 73, 108).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [72] Terada T, In vivo direct relation of tau pathology with neuroinflammation in early Alzheimer’s disease. Journal of neurology 266, 2186– 2196 (2019). 31139959 source
Not checked in the free run.
- cites [73] Brundin P, Melki R, Kopito R, Prion-like transmission of protein aggregates in neurodegenerative diseases. Nature reviews. Molecular cell biology 11, 301– 307 (2010). 20308987 PMC2892479 source
Not checked in the free run.
- cites [108] Holth JK, The sleep-wake cycle regulates brain interstitial fluid tau in mice and CSF tau in humans. Science 363, 880– 884 (2019). 30679382 PMC6410369 source
Not checked in the free run.
May combine two claims.
InterpretationreasoningDiagnostic neuroimaging of glymphatic function via glymphograms may provide a means to predict risk of proteinopathies and evaluate efficacy of glymphatic flow-directed treatments.
“The diagnostic neuroimaging of glymphatic function via such “glymphograms” may indeed provide both a means to predict the risk of developing proteinopathies, and an approach by which to evaluate the efficacy of glymphatic flow-directed treatments as they are developed.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationAmyloid-β, tau, and α-synuclein are present at higher levels in brain extracellular fluid and CSF during wakefulness than sleep; sleep deprivation increases their levels further.
“amyloid-ß, tau and α-synuclein are all present at higher levels in the brain extracellular fluid and CSF during wakefulness than during sleep, and sleep deprivation increases their levels further (106–108).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [106] Bateman RJ, Human amyloid-beta synthesis and clearance rates as measured in cerebrospinal fluid in vivo. Nature medicine 12, 856– 861 (2006). PMC2983090 16799555 source
Not checked in the free run.
- cites [107] Kang JE, Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle. Science 326, 1005– 1007 (2009). 19779148 PMC2789838 source
Not checked in the free run.
- cites [108] Holth JK, The sleep-wake cycle regulates brain interstitial fluid tau in mice and CSF tau in humans. Science 363, 880– 884 (2019). 30679382 PMC6410369 source
Not checked in the free run.
The paper relies on this without support.
For brain homeostasis, protein clearance must approximately equal protein synthesis.
“A fundamental tenet of brain homeostasis is that protein clearance must approximate protein synthesis.”
The paper relies on this without support.
The ejection pressure of blood from the left ventricle is partly absorbed by the elastic arterial wall of the aorta.
“To wit, the ejection pressure of blood from the left ventricle is partly absorbed by the elastic arterial wall of the aorta.”
The paper relies on this without support.
Pulsatility in large caliber arteries transmits pressure waves along the axis of major vessels and through soft brain tissue.
“Pulsatility in these large caliber arteries constantly transmits pressure waves along the axis of the major vessels, as well as through the soft brain tissue (Fig. 4).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Insomnia may partially mediate depression risk for Alzheimer's and related dementias via beta-amyloid accumulation, tau protein aggregation, inflammation and blood-brain-barrier disruption.
“Insomnia may partially mediate depression risk for Alzheimer's and related dementias via beta‐amyloid accumulation, tau protein aggregation, inflammation and blood‐brain‐barrier disruption204, 205, 206.”
From Mental health care for older adults: recent advances and new directions in clinical practice and research (2022) · cites this paper as [206]
Data-driven proteomic analyses have revealed several biological pathways and molecular functions associated with cognitive impairment in late-life major depression, related to neuro-inflammatory control, neurotrophic support, cell survival/apoptosis, endothelial function, and lipid/protein metabolism.
“Data‐driven proteomic analyses have revealed several biological pathways and molecular functions associated with cognitive impairment in late‐life major depression, related to neuro‐inflammatory control, neurotrophic support, cell survival/apoptosis, endothelial function, and lipid/protein metabolism204, 205, 206.”
From Mental health care for older adults: recent advances and new directions in clinical practice and research (2022) · cites this paper as [206]
Several lines of evidence implicate meningeal-located structures in the genesis and progression of Alzheimer's disease (AD).
“Several lines of evidence implicate meningeal-located structures in the genesis and progression of Alzheimer’s disease (AD)”
From Living on the Edge of the CNS: Meninges Cell Diversity in Health and Disease (2021) · cites this paper as Nedergaard and Goldman, 2020
The transport of interstitial fluids and macromolecules (including amyloid-β peptides) out of the brain occurs via a complex transport network that utilizes the perivascular glymphatic system of the brain and lymphatic vessels of the meninges.
“The transport of interstitial fluids and macromolecules (including amyloid-β peptides) out of the brain occurs via a complex transport network that utilizes the perivascular glymphatic system of the brain and lymphatic vessels of the meninges”
From Living on the Edge of the CNS: Meninges Cell Diversity in Health and Disease (2021) · cites this paper as Nedergaard and Goldman, 2020
Cites
Iliff, J. J., Wang, M., Liao, Y., Plogg, B. A., Peng, W., Gundersen, G. A., Benveniste, H., Vates, G. E., Deane, R., Goldman, S. A., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003748 · Cited by 5,824 · see citing works
Self-citationSleep Drives Metabolite Clearance from the Adult Brain
Xie, L., Kang, H., Xu, Q., Chen, M. J., Liao, Y., Thiyagarajan, M., O’Donnell, J., Christensen, D. J., Nicholson, C., Iliff, J. J., et al. (2013) · Science · doi:10.1126/science.1241224 · Cited by 5,411 · see citing works
Self-citationStructural and functional features of central nervous system lymphatic vessels
Louveau, A., Smirnov, I., Keyes, T. J., Eccles, J. D., Rouhani, S. J., Peske, J. D., Derecki, N. C., Castle, D., Mandell, J. W., Lee, K. S., et al. (2015) · Nature · doi:10.1038/nature14432 · Cited by 4,413 · see citing works
Two-Process Model of Sleep Regulation
Binder, M. D., Hirokawa, N., & Windhorst, U. (2008) · Springer eBooks · doi:10.1007/978-3-540-29678-2_6166 · Cited by 3,895 · see citing works
Complement and microglia mediate early synapse loss in Alzheimer mouse models
Hong, S., Beja-Glasser, V. F., Nfonoyim, B. M., Frouin, A., Li, S., Ramakrishnan, S., Merry, K. M., Shi, Q., Rosenthal, A., Barres, B. A., et al. (2016) · Science · doi:10.1126/science.aad8373 · Cited by 3,343 · see citing works
Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders
Zlokovic, B. V. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3114 · Cited by 2,969 · see citing works
Regularly Occurring Periods of Eye Motility, and Concomitant Phenomena, During Sleep
Aserinsky, E., & Kleitman, N. (1953) · Science · doi:10.1126/science.118.3062.273 · Cited by 2,488 · see citing works
Tononi, G., & Cirelli, C. (2014) · Neuron · doi:10.1016/j.neuron.2013.12.025 · Cited by 2,356 · see citing works
The blood–brain barrier: an overview
Ballabh, P., Braun, A., & Nedergaard, M. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.12.016 · Cited by 2,276 · see citing works
Self-citationA dural lymphatic vascular system that drains brain interstitial fluid and macromolecules
Aspelund, A., Antila, S., Proulx, S. T., Karlsen, T. V., Karaman, S., Detmar, M., Wiig, H., & Alitalo, K. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20142290 · Cited by 2,198 · see citing works
The Pathobiology of Vascular Dementia
Iadecola, C. (2013) · Neuron · doi:10.1016/j.neuron.2013.10.008 · Cited by 1,857 · see citing works
Small vessel disease: mechanisms and clinical implications
Wardlaw, J. M., Smith, C., & Dichgans, M. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(19)30079-1 · Cited by 1,777 · see citing works
Self-propagation of pathogenic protein aggregates in neurodegenerative diseases
Jucker, M., & Walker, L. C. (2013) · Nature · doi:10.1038/nature12481 · Cited by 1,663 · see citing works
Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging
Wardlaw, J. M., Smith, C., & Dichgans, M. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70060-7 · Cited by 1,657 · see citing works
The roles of intracellular protein-degradation pathways in neurodegeneration
Rubinsztein, D. C. (2006) · Nature · doi:10.1038/nature05291 · Cited by 1,625 · see citing works
The two‐process model of sleep regulation: a reappraisal
Borbély, A. A., Daan, S., Wirz‐Justice, A., & Deboer, T. (2016) · Journal of Sleep Research · doi:10.1111/jsr.12371 · Cited by 1,577 · see citing works
Amyloid-β Dynamics Are Regulated by Orexin and the Sleep-Wake Cycle
Kang, J.-E., Lim, M. M., Bateman, R. J., Lee, J. J., Smyth, L. P., Cirrito, J. R., Fujiki, N., Nishino, S., & Holtzman, D. M. (2009) · Science · doi:10.1126/science.1180962 · Cited by 1,565 · see citing works
Impairment of paravascular clearance pathways in the aging brain
Kress, B. T., Iliff, J. J., Xia, M., Wang, M., Wei, H. S., Zeppenfeld, D., Xie, L., Kang, H., Xu, Q., Liew, J. A., et al. (2014) · Annals of Neurology · doi:10.1002/ana.24271 · Cited by 1,521 · see citing works
Self-citationUnfolding the role of protein misfolding in neurodegenerative diseases
Soto, C. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1007 · Cited by 1,506 · see citing works
Functional aspects of meningeal lymphatics in ageing and Alzheimer’s disease
Da Mesquita, S., Louveau, A., Vaccari, A., Smirnov, I., Cornelison, R. C., Kingsmore, K. M., Contarino, C., Onengut-Gumuscu, S., Farber, E., Raper, D., et al. (2018) · Nature · doi:10.1038/s41586-018-0368-8 · Cited by 1,445 · see citing works
The sleep slow oscillation as a traveling wave
Massimini, M., Huber, R., Ferrarelli, F., Hill, S., & Tononi, G. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1318-04.2004 · Cited by 1,221 · see citing works
Coupled electrophysiological, hemodynamic, and cerebrospinal fluid oscillations in human sleep
Fultz, N. E., Bonmassar, G., Setsompop, K., Stickgold, R. A., Rosen, B. R., Polimeni, J. R., & Lewis, L. D. (2019) · Science · doi:10.1126/science.aax5440 · Cited by 1,197 · see citing works
Health consequences of shift work and insufficient sleep
Kecklund, G., & Axelsson, J. (2016) · BMJ · doi:10.1136/bmj.i5210 · Cited by 1,195 · see citing works
Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases
Soto, C., & Pritzkow, S. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0235-9 · Cited by 1,180 · see citing works
Impairment of Glymphatic Pathway Function Promotes Tau Pathology after Traumatic Brain Injury
Iliff, J. J., Chen, M. J., Plog, B. A., Zeppenfeld, D. M., Soltero, M., Yang, L., Singh, I., Deane, R., & Nedergaard, M. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.3020-14.2014 · Cited by 1,159 · see citing works
Self-citationFlow of cerebrospinal fluid is driven by arterial pulsations and is reduced in hypertension.
Mestre, H., Tithof, J., Du, T., Song, W., Peng, W., Sweeney, A. M., Olveda, G., Thomas, J. H., Nedergaard, M., & Kelley, D. H. (2018) · Nature Communications · doi:10.1038/s41467-018-07318-3 · Cited by 1,110 · see citing works
Self-citationβ-Amyloid accumulation in the human brain after one night of sleep deprivation
Shokri-Kojori, E., Wang, G.-J., Wiers, C. E., Demiral, S. B., Guo, M., Kim, S. W., Lindgren, E., Ramirez, V., Zehra, A., Freeman, C., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1721694115 · Cited by 893 · see citing works
Cardiovascular risk factors and cognitive decline in middle-aged adults
Knopman, D., Boland, L. L., Mosley, T., Howard, G., Liao, D., Szklo, M., McGovern, P., & Folsom, A. R. (2001) · Neurology · doi:10.1212/wnl.56.1.42 · Cited by 883 · see citing works
Perivascular spaces in the brain: anatomy, physiology and pathology
Wardlaw, J. M., Benveniste, H., Nedergaard, M., Zlokovic, B. V., Mestre, H., Lee, H., Doubal, F. N., Brown, R., Ramirez, J., MacIntosh, B. J., et al. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0312-z · Cited by 870 · see citing works
Self-citationVyazovskiy, V. V., Cirelli, C., Pfister-Genskow, M., Faraguna, U., & Tononi, G. (2008) · Nature Neuroscience · doi:10.1038/nn2035 · Cited by 837 · see citing works
The sleep-wake cycle regulates brain interstitial fluid tau in mice and CSF tau in humans
Holth, J. K., Fritschi, S. K., Wang, C., Pedersen, N. P., Cirrito, J. R., Mahan, T. E., Finn, M. B., Manis, M., Geerling, J. C., Fuller, P. M., et al. (2019) · Science · doi:10.1126/science.aav2546 · Cited by 813 · see citing works
Meningeal lymphatic vessels at the skull base drain cerebrospinal fluid
Ahn, J. H., Cho, H., Kim, J.-H., Kim, S. H., Ham, J.-S., Park, I., Suh, S. H., Hong, S. P., Song, J.-H., Hong, Y.-K., et al. (2019) · Nature · doi:10.1038/s41586-019-1419-5 · Cited by 811 · see citing works
Prion-like transmission of protein aggregates in neurodegenerative diseases
Brundin, P., Melki, R., & Kopito, R. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2873 · Cited by 778 · see citing works
Physiological Roles of Aquaporin-4 in Brain
Nagelhus, E. A., & Ottersen, O. P. (2013) · Physiological Reviews · doi:10.1152/physrev.00011.2013 · Cited by 766 · see citing works
Aquaporin-4-dependent glymphatic solute transport in the rodent brain
Mestre, H., Hablitz, L. M., Xavier, A. L., Feng, W., Zou, W., Pu, T., Monai, H., Murlidharan, G., Castellanos Rivera, R. M., Simon, M. J., et al. (2018) · eLife · doi:10.7554/elife.40070 · Cited by 738 · see citing works
Self-citationGlymphatic MRI in idiopathic normal pressure hydrocephalus
Ringstad, G., Vatnehol, S. A. S., & Eide, P. K. (2017) · Brain · doi:10.1093/brain/awx191 · Cited by 722 · see citing works
Vascular dysfunction—The disregarded partner of Alzheimer's disease
Sweeney, M. D., Montagne, A., Sagare, A. P., Nation, D. A., Schneider, L. S., Chui, H. C., Harrington, M. G., Pa, J., Law, M., Wang, D. J. J., et al. (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.07.222 · Cited by 711 · see citing works
Self-citationNedergaard, M. (2013) · Science · doi:10.1126/science.1240514 · Cited by 704 · see citing works
Self-citationCircadian control of brain glymphatic and lymphatic fluid flow
Hablitz, L. M., Plá, V., Giannetto, M., Vinitsky, H. S., Stæger, F. F., Metcalfe, T., Nguyen, R., Benrais, A., & Nedergaard, M. (2020) · Nature Communications · doi:10.1038/s41467-020-18115-2 · Cited by 704 · see citing works
Self-citationZeppenfeld, D. M., Simon, M., Haswell, J. D., D’Abreo, D., Murchison, C., Quinn, J. F., Grafe, M. R., Woltjer, R. L., Kaye, J., & Iliff, J. J. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2016.4370 · Cited by 651 · see citing works
Understanding the functions and relationships of the glymphatic system and meningeal lymphatics
Louveau, A., Plog, B. A., Antila, S., Alitalo, K., Nedergaard, M., & Kipnis, J. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90603 · Cited by 640 · see citing works
Self-citationHablitz, L. M., Vinitsky, H. S., Sun, Q., Stæger, F. F., Sigurdsson, B., Mortensen, K. N., Lilius, T. O., & Nedergaard, M. (2019) · Science Advances · doi:10.1126/sciadv.aav5447 · Cited by 629 · see citing works
Self-citationThe Brain’s Glymphatic System: Current Controversies
Mestre, H., Mori, Y., & Nedergaard, M. (2020) · Trends in Neurosciences · doi:10.1016/j.tins.2020.04.003 · Cited by 609 · see citing works
Self-citationHuman amyloid-β synthesis and clearance rates as measured in cerebrospinal fluid in vivo
Bateman, R. J., Munsell, L. Y., Morris, J. C., Swarm, R., Yarasheski, K. E., & Holtzman, D. M. (2006) · Nature Medicine · doi:10.1038/nm1438 · Cited by 599 · see citing works
Signaling at the Gliovascular Interface
Simard, M., Arcuino, G., Takano, T., Liu, Q. S., & Nedergaard, M. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-27-09254.2003 · Cited by 586 · see citing works
Self-citationSuppression of glymphatic fluid transport in a mouse model of Alzheimer's disease
Peng, W., Achariyar, T. M., Li, B., Liao, Y., Mestre, H., Hitomi, E., Regan, S., Kasper, T., Peng, S., Ding, F., et al. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.05.015 · Cited by 580 · see citing works
Self-citationUltrastructural evidence for synaptic scaling across the wake/sleep cycle
de Vivo, L., Bellesi, M., Marshall, W., Bushong, E. A., Ellisman, M. H., Tononi, G., & Cirelli, C. (2017) · Science · doi:10.1126/science.aah5982 · Cited by 574 · see citing works
Prefrontal atrophy, disrupted NREM slow waves and impaired hippocampal-dependent memory in aging
Mander, B. A., Rao, V. R., Lu, B. S., Saletin, J., Lindquist, J. R., Ancoli‐Israel, S., Jagust, W. J., & Walker, M. P. (2013) · Nature Neuroscience · doi:10.1038/nn.3324 · Cited by 565 · see citing works
Brain-wide glymphatic enhancement and clearance in humans assessed with MRI.
Ringstad, G., Valnes, L. M., Dale, A. M., Pripp, A. H., Vatnehol, S.-A. S., Emblem, K. E., Mardal, K.-A., & Eide, P. K. (2018) · JCI Insight · doi:10.1172/jci.insight.121537 · Cited by 533 · see citing works
The Glymphatic System and Waste Clearance with Brain Aging: A Review
Benveniste, H., Liu, X., Koundal, S., Sanggaard, S., Lee, H., & Wardlaw, J. (2019) · Gerontology · doi:10.1159/000490349 · Cited by 517 · see citing works
Deletion of aquaporin-4 in APP/PS1 mice exacerbates brain Aβ accumulation and memory deficits
Xu, Z., Xiao, N., Chen, Y., Huang, H., Marshall, C., Gao, J., Cai, Z., Wu, T., Hu, G., & Xiao, M. (2015) · Molecular Neurodegeneration · doi:10.1186/s13024-015-0056-1 · Cited by 500 · see citing works
Cerebrospinal fluid influx drives acute ischemic tissue swelling
Mestre, H., Du, T., Sweeney, A. M., Liu, G., Samson, A. J., Peng, W., Mortensen, K. N., Stæger, F. F., Bork, P. A. R., Bashford, L., et al. (2020) · Science · doi:10.1126/science.aax7171 · Cited by 494 · see citing works
Self-citationSleep modulates haematopoiesis and protects against atherosclerosis
McAlpine, C. S., Kiss, M. G., Rattik, S., He, S., Vassalli, A., Valet, C., Anzai, A., Chan, C. T., Mindur, J. E., Kahles, F., et al. (2019) · Nature · doi:10.1038/s41586-019-0948-2 · Cited by 447 · see citing works
Kiviniemi, V. J., Wang, X., Korhonen, V. O., Keinänen, T., Tuovinen, T., Autio, J. A., LeVan, P., Keilholz, S. D., Zang, Y., Hennig, J., et al. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x15622047 · Cited by 443 · see citing works
Self-citationSleep is of the brain, by the brain and for the brain
Hobson, J. A. (2005) · Nature · doi:10.1038/nature04283 · Cited by 440 · see citing works
Lymphatic pumping: mechanics, mechanisms and malfunction
Scallan, J. P., Zawieja, S. D., Castorena‐Gonzalez, J. A., & Davis, M. J. (2016) · The Journal of Physiology · doi:10.1113/jp272088 · Cited by 424 · see citing works
Perivascular spaces, glymphatic dysfunction, and small vessel disease
Mestre, H., Kostrikov, S., Mehta, R. I., & Nedergaard, M. (2017) · Clinical Science · doi:10.1042/cs20160381 · Cited by 403 · see citing works
Self-citationZou, W., Pu, T., Feng, W., Lu, M., Zheng, Y., Du, R., Xiao, M., & Hu, G. (2019) · Translational Neurodegeneration · doi:10.1186/s40035-019-0147-y · Cited by 396 · see citing works
Cardiovascular fitness is associated with cognition in young adulthood
Åberg, M. A. I., Pedersen, N. L., Torén, K., Svartengren, M., Bäckstrand, B., Johnsson, T., Cooper-Kuhn, C. M., Åberg, N. D., Nilsson, M., & Kuhn, H. G. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905307106 · Cited by 382 · see citing works
Dementia After Stroke: The Framingham Study
Ivan, C. S., Seshadri, S., Beiser, A., Au, R., Kase, C. S., Kelly-Hayes, M., & Wolf, P. A. (2004) · Stroke · doi:10.1161/01.str.0000127810.92616.78 · Cited by 369 · see citing works
A common mechanism of proteasome impairment by neurodegenerative disease-associated oligomers
Thibaudeau, T. A., Anderson, R. T., & Smith, D. M. (2018) · Nature Communications · doi:10.1038/s41467-018-03509-0 · Cited by 362 · see citing works
Impact of sleep on the risk of cognitive decline and dementia
Spira, A. P., Chen-Edinboro, L. P., Wu, M. N., & Yaffe, K. S. (2014) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000106 · Cited by 310 · see citing works
Henderson, M. X., Cornblath, E. J., Darwich, A., Zhang, B., Brown, H., Gathagan, R. J., Sandler, R. M., Bassett, D. S., Trojanowski, J. Q., & Lee, V. M. Y. (2019) · Nature Neuroscience · doi:10.1038/s41593-019-0457-5 · Cited by 310 · see citing works
Human Cortical Excitability Increases with Time Awake
Huber, R., Mäki, H., Rosanova, M., Casarotto, S., Canali, P., Casali, A. G., Tononi, G., & Massimini, M. (2012) · Cerebral Cortex · doi:10.1093/cercor/bhs014 · Cited by 308 · see citing works
Impairment of the glymphatic system after diabetes
Jiang, Q., Zhang, L., Ding, G., Davoodi-Bojd, E., Li, Q., Li, L., Sadry, N., Nedergaard, M., Chopp, M., & Zhang, Z. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16654702 · Cited by 308 · see citing works
Self-citationImpairment of the Glymphatic Pathway and Putative Meningeal Lymphatic Vessels in the Aging Human
Zhou, Y., Cai, J., Zhang, W., Gong, X., Yan, S., Zhang, K., Luo, Z., Sun, J., Jiang, Q., & Lou, M. (2020) · Annals of Neurology · doi:10.1002/ana.25670 · Cited by 305 · see citing works
Impaired Glymphatic Transport in Spontaneously Hypertensive Rats
Mortensen, K. N., Sanggaard, S., Mestre, H., Lee, H., Kostrikov, S., Xavier, A. L. R., Gjedde, A., Benveniste, H., & Nedergaard, M. (2019) · The Journal of Neuroscience · doi:10.1523/jneurosci.1974-18.2019 · Cited by 266 · see citing works
Self-citationSleep-wake cycles drive daily dynamics of synaptic phosphorylation
Brüning, F., Noya, S. B., Bange, T., Koutsouli, S., Rudolph, J. D., Tyagarajan, S. K., Cox, J., Mann, M., Brown, S. A., & Robles, M. S. (2019) · Science · doi:10.1126/science.aav3617 · Cited by 261 · see citing works
The forebrain synaptic transcriptome is organized by clocks but its proteome is driven by sleep
Noya, S. B., Colameo, D., Brüning, F., Spinnler, A., Mircsof, D., Opitz, L., Mann, M., Tyagarajan, S. K., Robles, M. S., & Brown, S. A. (2019) · Science · doi:10.1126/science.aav2642 · Cited by 248 · see citing works
Cerebrospinal Fluid Clearance in Alzheimer Disease Measured with Dynamic PET
de Leon, M. J., Li, Y., Okamura, N., Tsui, W. H., Saint-Louis, L. A., Glodzik, L., Osorio, R. S., Fortea, J., Butler, T., Pirraglia, E., et al. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.187211 · Cited by 246 · see citing works
Self-citationAn ocular glymphatic clearance system removes β-amyloid from the rodent eye
Wang, X., Lou, N., Eberhardt, A., Yang, Y., Kusk, P., Xu, Q., Förstera, B., Peng, S., Shi, M., Ladrón-de-Guevara, A., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aaw3210 · Cited by 239 · see citing works
Self-citationObstructive sleep apnea, hypertension and cardiovascular diseases
Gonzaga, C., Bertolami, A., Bertolami, M., Amodeo, C., & Calhoun, D. (2015) · Journal of Human Hypertension · doi:10.1038/jhh.2015.15 · Cited by 230 · see citing works
Weller, R. O. (1998) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199810000-00001 · Cited by 224 · see citing works
LRP1 in Brain Vascular Smooth Muscle Cells Mediates Local Clearance of Alzheimer's Amyloid-β
Kanekiyo, T., Liu, C., Shinohara, M., Li, J., & Bu, G. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.3987-12.2012 · Cited by 221 · see citing works
Sleep loss and circadian disruption in shift work: health burden and management
Rajaratnam, S. M. W., Howard, M. E., & Grunstein, R. R. (2013) · The Medical Journal of Australia · doi:10.5694/mja13.10561 · Cited by 210 · see citing works
Rapid lymphatic efflux limits cerebrospinal fluid flow to the brain
Ma, Q., Ries, M., Decker, Y., Müller, A., Riner, C., Bücker, A., Fassbender, K., Detmar, M., & Proulx, S. T. (2019) · Acta Neuropathologica · doi:10.1007/s00401-018-1916-x · Cited by 210 · see citing works
Age-dependent changes in sleep EEG topography
Landolt, H.-P., & Borbély, A. A. (2001) · Clinical Neurophysiology · doi:10.1016/s1388-2457(00)00542-3 · Cited by 200 · see citing works
Deep cervical lymph node ligation aggravates AD‐like pathology of APP/PS1 mice
Wang, L., Zhang, Y., Zhao, Y., Marshall, C., Wu, T., & Xiao, M. (2019) · Brain Pathology · doi:10.1111/bpa.12656 · Cited by 199 · see citing works
Profile of Cognitive Impairment in Chronic Heart Failure
Vogels, R. L. C., Oosterman, J. M., Van Harten, B., Scheltens, P., Van Der Flier, W. M., Schroeder‐Tanka, J. M., & Weinstein, H. C. (2007) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2007.01395.x · Cited by 194 · see citing works
A sleep-inducing gene, nemuri , links sleep and immune function in Drosophila
Toda, H., Williams, J. A., Gulledge, M., & Sehgal, A. (2019) · Science · doi:10.1126/science.aat1650 · Cited by 191 · see citing works
Cardiovascular Disease Risk Factors and Cognition in the Elderly
Leritz, E. C., McGlinchey, R. E., Kellison, I., Rudolph, J. L., & Milberg, W. P. (2011) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-011-0189-x · Cited by 188 · see citing works
Sundaram, S., Hughes, R. L., Peterson, E., Müller-Oehring, E. M., Brontë-Stewart, H. M., Poston, K. L., Faerman, A., Bhowmick, C., & Schulte, T. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.05.016 · Cited by 152 · see citing works
Roeters, S. J., Iyer, A., Pletikapić, G., Kogan, V., Subramaniam, V., & Woutersen, S. (2017) · Scientific Reports · doi:10.1038/srep41051 · Cited by 146 · see citing works
Rainey-Smith, S. R., Mazzucchelli, G. N., Villemagne, V. L., Brown, B. M., Porter, T., Weinborn, M., Bucks, R. S., Milicic, L., Sohrabi, H. R., Taddei, K., et al. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0094-x · Cited by 144 · see citing works
Anatomy and function of the vertebral column lymphatic network in mice
Jacob, L., Boisserand, L. S. B., Geraldo, L. H. M., de Brito Neto, J., Mathivet, T., Antila, S., Barka, B., Xu, Y., Thomas, J.-M., Pestel, J., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12568-w · Cited by 144 · see citing works
Burfeind, K. G., Murchison, C. F., Westaway, S. K., Simon, M. J., Erten‐Lyons, D., Kaye, J. A., Quinn, J. F., & Iliff, J. J. (2017) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2017.05.001 · Cited by 136 · see citing works
Clearance of cerebrospinal fluid from the sacral spine through lymphatic vessels
Ma, Q., Decker, Y., Müller, A., Ineichen, B. V., & Proulx, S. T. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20190351 · Cited by 136 · see citing works
Intercellular Spread of Protein Aggregates in Neurodegenerative Disease
Davis, A. A., Leyns, C. E. G., & Holtzman, D. M. (2018) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-100617-062636 · Cited by 131 · see citing works
Cleaning the sleeping brain – the potential restorative function of the glymphatic system
Hauglund, N. L., Pavan, C., & Nedergaard, M. (2020) · Current Opinion in Physiology · doi:10.1016/j.cophys.2019.10.020 · Cited by 129 · see citing works
Self-citationComorbid Sleep Disorders in Neuropsychiatric Disorders Across the Life Cycle
Spiegelhalder, K., Regen, W., Nanovska, S., Baglioni, C., & Riemann, D. W. (2013) · Current Psychiatry Reports · doi:10.1007/s11920-013-0364-5 · Cited by 127 · see citing works
Burke, K. A., Yates, E. A., & Legleiter, J. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00017 · Cited by 127 · see citing works
Neurodegenerative Disorders and Sleep
Malhotra, R. K. (2018) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2017.09.006 · Cited by 127 · see citing works
Outer brain barriers in rat and human development
Brøchner, C. B., Holst, C. B., & Møllgård, K. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00075 · Cited by 104 · see citing works
Cardiorespiratory Fitness and Accelerated Cognitive Decline With Aging
Wendell, C. R., Gunstad, J., Waldstein, S. R., Wright, J. G., Ferrucci, L., & Zonderman, A. B. (2014) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glt144 · Cited by 104 · see citing works
Hydraulic resistance of periarterial spaces in the brain
Tithof, J., Kelley, D. H., Mestre, H., Nedergaard, M., & Thomas, J. H. (2019) · Fluids and Barriers of the CNS · doi:10.1186/s12987-019-0140-y · Cited by 98 · see citing works
Self-citationPlasticity during sleep is linked to specific regulation of cortical circuit activity
Niethard, N., Burgalossi, A., & Born, J. (2017) · Frontiers in Neural Circuits · doi:10.3389/fncir.2017.00065 · Cited by 89 · see citing works
(2020) · International Review of Neurobiology · doi:10.1016/bs.irn.2020.02.006 · Cited by 87 · see citing works
Itani, O., Kaneita, Y., Tokiya, M., Jike, M., Murata, A., Nakagome, S., Otsuka, Y., & Ohida, T. (2017) · Sleep Medicine · doi:10.1016/j.sleep.2017.07.027 · Cited by 86 · see citing works
Rodriguez, A. V., Funk, C. M., Vyazovskiy, V. V., Nir, Y., Tononi, G., & Cirelli, C. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.1614-16.2016 · Cited by 76 · see citing works
Vascular pathology: Cause or effect in Alzheimer disease?
Rius‐Pérez, S., Tormos, A. M., Pérez, S., & Taléns‐Visconti, R. (2017) · Neurología (English Edition) · doi:10.1016/j.nrleng.2015.07.008 · Cited by 75 · see citing works
Simon, M. J., Wang, M. X., Murchison, C. F., Roese, N. E., Boespflug, E. L., Woltjer, R. L., & Iliff, J. J. (2018) · Scientific Reports · doi:10.1038/s41598-018-30779-x · Cited by 71 · see citing works
Xue, Y., Liu, N., Zhang, M., Ren, X., Tang, J., & Fu, J. (2020) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2020.04.008 · Cited by 71 · see citing works
Patología vascular: ¿causa o efecto en la enfermedad de Alzheimer?
Rius‐Pérez, S., Tormos, A. M., Pérez, S., & Taléns‐Visconti, R. (2015) · Neurología · doi:10.1016/j.nrl.2015.07.010 · Cited by 70 · see citing works
Evidence for lymphatic Aβ clearance in Alzheimer's transgenic mice
Pappolla, M., Sambamurti, K., Vidal, R., Pacheco-Quinto, J., Poeggeler, B., & Matsubara, E. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.07.012 · Cited by 69 · see citing works
Shift work and risk of incident dementia: a study of two population-based cohorts
Bokenberger, K., Sjölander, A., Aslan, A. K. D., Karlsson, I., Åkerstedt, T., & Pedersen, N. L. (2018) · European Journal of Epidemiology · doi:10.1007/s10654-018-0430-8 · Cited by 69 · see citing works
In vivo direct relation of tau pathology with neuroinflammation in early Alzheimer’s disease
Terada, T., Yokokura, M., Obi, T., Bunai, T., Yoshikawa, E., Ando, I., Shimada, H., Suhara, T., Higuchi, M., & Ouchi, Y. (2019) · Journal of Neurology · doi:10.1007/s00415-019-09400-2 · Cited by 60 · see citing works
Ulv Larsen, S. M., Landolt, H.-P., Berger, W., Nedergaard, M., Knudsen, G. M., & Holst, S. C. (2020) · PLOS Biology · doi:10.1371/journal.pbio.3000623 · Cited by 60 · see citing works
Self-citationSpecific Domains of Aβ Facilitate Aggregation on and Association with Lipid Bilayers
Yates, E. A., Owens, S. L., Lynch, M. F., Cucco, E. M., Umbaugh, C. S., & Legleiter, J. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.03.022 · Cited by 41 · see citing works
Age as Risk Factor for Sporadic Dementia of the Alzheimer Type?
HOYER, S. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb56833.x · Cited by 38 · see citing works
Leigh, L., Hudson, I. L., & Byles, J. (2015) · Journal of Sleep Research · doi:10.1111/jsr.12324 · Cited by 37 · see citing works
Lymphatic Capillaries in Aging
Jakic, B., Kerjaschki, D., & Wick, G. (2020) · Gerontology · doi:10.1159/000508459 · Cited by 28 · see citing works
Shear-Induced Amyloid Formation in the Brain: I. Potential Vascular and Parenchymal Processes
Trumbore, C. N. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-160027 · Cited by 27 · see citing works
A Nanoparticle-Based Assay To Evaluate Surface-Induced Antibody Instability
Kopp, M. R. G., Palmiero, U. C., & Arosio, P. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b01168 · Cited by 23 · see citing works
Sleep Deprivation as a Method of EEG Activation
Logothetis, J. A., Milonas, I., & Bostantzopoulou, S. (2008) · European Neurology · doi:10.1159/000116094 · Cited by 18 · see citing works
Sleep in Neurodegenerative Disorders
Malkani, R., & Attarian, H. (2015) · Current Sleep Medicine Reports · doi:10.1007/s40675-015-0016-x · Cited by 12 · see citing works
Sifting through a failed Alzheimer trial: What biomarkers tell us about what happened
Knopman, D. S. (2018) · Neurology · doi:10.1212/wnl.0000000000005073 · Cited by 5 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Rasmussen, M. K., Mestre, H., & Nedergaard, M. (2021) · Physiological Reviews · doi:10.1152/physrev.00031.2020 · Cited by 622 · see citing works
Self-citationNeuroinflammation in Alzheimer disease
Heneka, M. T., van der Flier, W. M., Jessen, F., Hoozemanns, J., Thal, D. R., Boche, D., Brosseron, F., Teunissen, C., Zetterberg, H., Jacobs, A. H., et al. (2025) · Nature Reviews Immunology · doi:10.1038/s41577-024-01104-7 · Cited by 638 · see citing works
“Arterial pulsations drive CSF from peri-arterial to intraparenchymal spaces, and this CSF is then reabsorbed at the peri-venule spaces with the aid of the glial AQP4 molecule 422,423 .”
The Glymphatic System: A Novel Component of Fundamental Neurobiology
Hablitz, L. M., & Nedergaard, M. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.0619-21.2021 · Cited by 480 · see citing works
“…with their implications for neuropathology, have been reviewed at length in the recent literature (Kent and Mistlberger, 2017; Abbott et al., 2018; Rasmussen et al., 2018; Sun et al., 2018; Thomas, 2019; Nedergaard and Goldman, 2020; Troili et al., 2020; Wardlaw et al., 2020; Mestre et al., 2020a).”
BackgroundSelf-citationReynolds, C. F., Jeste, D. V., Sachdev, P. S., & Blazer, D. G. (2022) · World Psychiatry · doi:10.1002/wps.20996 · Cited by 465 · see citing works
Mou, Y., Du, Y., Zhou, L., Yue, J., Hu, X., Liu, Y., Chen, S., Lin, X., Zhang, G., Xiao, H., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.796288 · Cited by 432 · see citing works
“The concept of glymphatic innovates a previous conjecture that brain homeostasis depends on the classical cellular protein degradation pathway to maintain the protein balance between synthesis and clearance (55).”
BackgroundThe glymphatic system: Current understanding and modeling
Bohr, T., Hjorth, P. G., Holst, S. C., Hrabětová, S., Kiviniemi, V. J., Lilius, T. O., Lundgaard, I., Mardal, K., Martens, E. A., Mori, Y., et al. (2022) · iScience · doi:10.1016/j.isci.2022.104987 · Cited by 381 · see citing works
“(Wedirect readers to other recent publications for excellent reviews of the glymphatic system (Rasmussen et al., 2021; Benveniste et al., 2019b; Nedergaard and Goldman, 2020; Ray and Heys, 2019; Linninger et al., 2016) and alternate perspectives on cerebrospinal fluid flow in the brain (Hladky and…”
Self-citationMultisensory gamma stimulation promotes glymphatic clearance of amyloid
Murdock, M. H., Yang, C.-Y., Sun, N., Pao, P., Blanco‐Duque, C., Kahn, M. C., Kim, T., Lavoie, N., Victor, M. B., Islam, R., et al. (2024) · Nature · doi:10.1038/s41586-024-07132-6 · Cited by 370 · see citing works
“The meningeal lymphatic drainage network, arterial-driven CSF movement and neuronal network dysfunction contribute to amyloid pathology in Alzheimer’s disease 14 .”
BackgroundVascular Cognitive Impairment (VCI)
Rundek, T., Tolea, M. I., Ariko, T., Fagerli, E. A., & Camargo, C. J. (2021) · Neurotherapeutics · doi:10.1007/s13311-021-01170-y · Cited by 325 · see citing works
“PVS have little to no resistance to flow [47] and have been proposed in the mechanisms Fig.”
BackgroundLee, J., & Kim, H.-J. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.931536 · Cited by 310 · see citing works
“Furthermore, WM changes are related to arteriolosclerosis of small vessels, resulting in incomplete ischemia and cell death and the emergence of perivascular spaces that interfere with the glymphatic drainage of the brain’s waste products (Nedergaard and Goldman, 2020).”
BackgroundEmerging roles for dynamic aquaporin-4 subcellular relocalization in CNS water homeostasis
Salman, M. M., Kitchen, P., Halsey, A., Wang, M. X., Törnroth-Horsefield, S., Conner, A. C., Badaut, J., Iliff, J. J., & Bill, R. M. (2022) · Brain · doi:10.1093/brain/awab311 · Cited by 303 · see citing works
“Given the role of perivascular glymphatic exchange in amyloid-b(41,49) and tau(50,51) clearance, impairment of glymphatic pathway function is now proposed to be important in the development of these conditions.(64) While imaging of glymphatic function using dynamic contrast-enhanced MRI (DCE-MRI) has only recently beg…”
BackgroundHuang, S., Zhang, Y.-R., Guo, Y., Du, J., Ren, P., Wu, B., Feng, J., Initiative, A. D. N., Cheng, W., & Yu, J. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13789 · Cited by 292 · see citing works
Hsu, J., Wei, Y., Toh, C., Hsiao, I., Lin, K., Yen, T., Liao, M., & Ro, L. (2022) · Annals of Neurology · doi:10.1002/ana.26516 · Cited by 261 · see citing works
“tem has been proposed as the final common pathway for AD and other primary neurodegenerative diseases.(6) Several magnetic resonance imaging (MRI) methods have been proposed to investigate the glymphatic system in humans.”
BackgroundThe glymphatic hypothesis: the theory and the evidence
Hladky, S. B., & Barrand, M. A. (2022) · Fluids and Barriers of the CNS · doi:10.1186/s12987-021-00282-z · Cited by 271 · see citing works
The glymphatic system: implications for drugs for central nervous system diseases
Lohela, T. J., Lilius, T. O., & Nedergaard, M. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00500-9 · Cited by 246 · see citing works
Self-citationThe Glymphatic System (En)during Inflammation
Mogensen, F. L., Delle, C., & Nedergaard, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147491 · Cited by 214 · see citing works
“It is clear that the glymphatic system is affected in chronic neuroinflammatory diseases such as Alzheimer’s disease [27,42], and could therefore be a potential therapeutic target.”
BackgroundSelf-citationArterial stiffness and vascular aging: mechanisms, prevention, and therapy
Herzog, M. J., Müller, P., Lechner, K., Stiebler, M., Arndt, P., Kunz, M., Ahrens, D., Schmeißer, A., Schreiber, S., & Braun-Dullaeus, R. C. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02346-0 · Cited by 246 · see citing works
Cerebral small vessel disease and vascular cognitive impairment: from diagnosis to management
Zotin, M. C. Z., Sveikata, L., Viswanathan, A., & Yilmaz, P. (2021) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000913 · Cited by 203 · see citing works
Siow, T. Y., Toh, C., Hsu, J., Liu, G.-H., Lee, S., Chen, N., Fu, C. J., Castillo, M., & Fang, J. (2021) · Neurology · doi:10.1212/wnl.0000000000013215 · Cited by 178 · see citing works
“The CSF interstitial fluid is then directed towards the venous PVS, ultimately resulting in fluid movement across the brain parenchyma to rid it of metabolic waste.(3,4)”
BackgroundNeurovascular coupling: motive unknown
Drew, P. J. (2022) · Trends in Neurosciences · doi:10.1016/j.tins.2022.08.004 · Cited by 160 · see citing works
Luo, A., Xie, Z., Wang, Y., Wang, X., Li, S., Yan, J., Zhan, G., Zhou, Z., Zhao, Y., & Li, S. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104642 · Cited by 166 · see citing works
Iadecola, C., Smith, E. E., Anrather, J., Gu, C., Mishra, A., Misra, S., Pérez‐Pinzón, M. A., Shih, A. Y., Sorond, F. A., van Veluw, S. J., et al. (2023) · Stroke · doi:10.1161/str.0000000000000431 · Cited by 156 · see citing works
Sleep and circadian rhythmicity as entangled processes serving homeostasis
Franken, P., & Dijk, D.-J. (2024) · Nature Reviews Neuroscience · doi:10.1038/s41583-023-00764-z · Cited by 147 · see citing works
The foundation and architecture of precision medicine in neurology and psychiatry
Hampel, H. J., Gao, P., Cummings, J. L., Toschi, N., Thompson, P. M., Hu, Y., Cho, M., & Vergallo, A. (2023) · Trends in Neurosciences · doi:10.1016/j.tins.2022.12.004 · Cited by 149 · see citing works
“At this point, homeostasis, with the underlying core biological feedback loops and networks and systems have been overwhelmed and begin to break down at varying points along the spatial and temporal continuum with decompensation and subsequent system failure in an individual manner [16,17].”
The Neurovascular Unit Dysfunction in Alzheimer’s Disease
Soto-Rojas, L. O., Pacheco‐Herrero, M., Martínez-Gómez, P. A., Campa-Córdoba, B. B., Apátiga-Pérez, R., Villegas-Rojas, M. M., Harrington, C. R., de la Cruz, F., Garcés‐Ramírez, L., & Luna‐Muñoz, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22042022 · Cited by 140 · see citing works
“Dysfunction of the glymphatic system has been observed in AD animal models, most likely because of the dysfunction of AQP4, which increases both Aβ plaque formation and cognitive deficits [24,98].”
BackgroundLin, Y., Jin, J., Lv, R., Luo, Y. M., Dai, W.-P., Li, W., Tang, Y., Wang, Y., Ye, X., & Lin, W. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01198-3 · Cited by 138 · see citing works
Li, Y., Zhou, Y., Zhong, W., Xiao, Z., Chen, Y., Zhang, K., He, Y., Luo, Z., Wang, R., Sun, J., et al. (2023) · Annals of Neurology · doi:10.1002/ana.26648 · Cited by 135 · see citing works
Hong, H., Hong, L., Luo, X., Zeng, Q., Li, K., Wang, S., Jiaerken, Y., Zhang, R., Yu, X., Zhang, Y., et al. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01407-w · Cited by 135 · see citing works
“…is recently proposed as the final common pathway to dementia because it contributes to the aggregation of proteins, activates neuroinflammation and facilitates a positive feedback loop between wastes accumulation and further glymphatic dysfunction, and finally causes brain injury and dementia [2].”
BackgroundResultLiving on the Edge of the CNS: Meninges Cell Diversity in Health and Disease
Derk, J., Jones, H. E., Como, C., Pawlikowski, B., & Siegenthaler, J. A. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.703944 · Cited by 120 · see citing works
“…contiguous extension of primary tumors of the central nervous system, paranasal sinuses and skull base origin or tumor metastasis which can lead to dissemination into the CNS parenchyma and poor prognosis (Mahendru and Chong, 2009; Waki et al., 2009; Oechsle et al., 2010; Scott and Kesari, 2013).”
BackgroundRegional Glymphatic Abnormality in Behavioral Variant Frontotemporal Dementia
Jiang, D., Liu, L., Kong, Y., Chen, Z., Rosa‐Neto, P., Chen, K., Ren, L., Chu, M., Wu, L., & Initiative, F. L. D. N. (2023) · Annals of Neurology · doi:10.1002/ana.26710 · Cited by 133 · see citing works
White matter aging and its impact on brain function
Groh, J., & Simons, M. (2025) · Neuron · doi:10.1016/j.neuron.2024.10.019 · Cited by 124 · see citing works
Antignano, I., Liu, Y., Offermann, N., & Capasso, M. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04775-y · Cited by 117 · see citing works
“It is known that CNS drainage decreases with age in human subjects [105] and that a correct function of the brain lymphatic system depends on sleep, which is known to be altered in aging [106].”
BackgroundDirect Measurement of Cerebrospinal Fluid Production in Mice
Liu, G., Mestre, H., Sweeney, A. M., Sun, Q., Weikop, P., Du, T., & Nedergaard, M. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108524 · Cited by 129 · see citing works
“The glymphatic/lymphatic system plays an important role in clearance of proteins implicated in neurodegenerative diseases (Benveniste et al., 2019; Nedergaard and Goldman, 2020).”
BackgroundSelf-citationA daily temperature rhythm in the human brain predicts survival after brain injury
Rzechorzek, N. M., Thrippleton, M. J., Chappell, F. M., Mair, G., Ercole, A., Cabeleira, M. T., Rhodes, J. K. J., Marshall, I., & O'Neill, J. S. (2021) · Brain · doi:10.1093/brain/awab466 · Cited by 128 · see citing works
“mechanism progressively deteriorates with age (Supplementary material).(82,83) Neuronal activity is highly sensitive to temperature change, with a Q10 of 2.”
Liu, X., Barisano, G., Shao, X., Jann, K., Ringman, J. M., Lu, H., Arfanakis, K., Caprihan, A., DeCarli, C. S., Gold, B. T., et al. (2023) · Aging and Disease · doi:10.14336/ad.2023.0321-2 · Cited by 123 · see citing works
“Additionally, GS dysfunction is related to sleep disorder as well as tau and beta-amyloid (Aβ) protein accumulations, which underlie the pathogenesis of cognitive impairment and dementia [16–21].”
BackgroundOsorio-Forero, A., Foustoukos, G., Cardis, R., Cherrad, N., Devenoges, C., Fernandez, L. M. J., & Lüthi, A. (2024) · Nature Neuroscience · doi:10.1038/s41593-024-01822-0 · Cited by 166 · see citing works
“Neverthe-less, we note that the noradrenergic LC is implied in neuronal and glial activity regulation and it might also support vasomotor activity in the brain during NREMS 5,49 .”
Advances in Applying Computer-Aided Drug Design for Neurodegenerative Diseases
Salman, M. M., Al-Obaidi, Z. M. J., Kitchen, P., Loreto, A., Bill, R. M., & Wade‐Martins, R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094688 · Cited by 119 · see citing works
“…glymphatic waste clearance system suggests that reduced glymphatic function is correlated with A and Bulk flow through the glymphatic system is elevated during sleep and mediated by the water channel protein AQP4, which is also implicated in various CNS pathologies [74–76]. tau accumulation [73].”
BackgroundGlymphatic Dysfunction in Patients With Ischemic Stroke
Toh, C., & Siow, T. Y. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.756249 · Cited by 115 · see citing works
The Glymphatic System in Humans: Investigations With Magnetic Resonance Imaging
Naganawa, S., Taoka, T., Ito, R., & Kawamura, M. (2023) · Investigative Radiology · doi:10.1097/rli.0000000000000969 · Cited by 115 · see citing works
Hablitz, L. M., & Nedergaard, M. (2021) · Current Biology · doi:10.1016/j.cub.2021.08.026 · Cited by 119 · see citing works
Self-citationAging drives cerebrovascular network remodeling and functional changes in the mouse brain
Bennett, H. C., Zhang, Q., Wu, Y.-T., Manjila, S. B., Chon, U., Shin, D., Vanselow, D. J., Pi, H.-J., Drew, P. J., & Kim, Y. (2024) · Nature Communications · doi:10.1038/s41467-024-50559-8 · Cited by 109 · see citing works
Cai, Y., Zhang, Y., Leng, S., Ma, Y., Jiang, Q., Wen, Q., Ju, S., & Hu, J. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106426 · Cited by 111 · see citing works
“Dysfunction in the glymphatic system has been proposed as the potential common pathway for AD and other primary neurodegenerative diseases (Nedergaard and Goldman, 2020).”
Brouillard, P., Witte, M. H., Erickson, R. P., Damstra, R. J., Becker, C., Quéré, I., & Vikkula, M. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00309-7 · Cited by 110 · see citing works
Tang, J., Zhang, M., Liu, N., Yang, X., Ren, X., Huang, Q., Shi, L., & Fu, J. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.916633 · Cited by 106 · see citing works
“This CSFISF exchange system is called the glymphatic system, and its main role includes metabolic product transportation and metabolic waste elimination (Nedergaard and Goldman, 2020).”
BackgroundLal, C., Ayappa, I. A., Ayas, N., Beaudin, A. E., Hoyos, C. M., Kushida, C. A., Kamińska, M., Mullins, A. E., Naismith, S. L., Osorio, R. S., et al. (2022) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202205-380st · Cited by 109 · see citing works
Decreased CSF clearance and increased brain amyloid in Alzheimer’s disease
Li, Y., Rusinek, H., Butler, T., Glodzik, L., Pirraglia, E., Babich, J. W., Mozley, P. D., Nehmeh, S. A., Pahlajani, S. S., Wang, X. H., et al. (2022) · Fluids and Barriers of the CNS · doi:10.1186/s12987-022-00318-y · Cited by 105 · see citing works
“In transgenic AD models, these clearance deficits are progressive [11].”
BackgroundKelley, D. H., & Thomas, J. H. (2022) · Annual Review of Fluid Mechanics · doi:10.1146/annurev-fluid-120720-011638 · Cited by 106 · see citing works
Sansores‐España, L. D., Melgar-Rodríguez, S. A., Sagredo-Olivares, K., Cafferata, E. A., Martínez-Aguilar, V. M., Vernal, R., Paula-Lima, A. C., & Díaz-Zúñiga, J. A. (2021) · Frontiers in Aging · doi:10.3389/fragi.2021.781582 · Cited by 106 · see citing works
“The teeth loss and the subsequent decrease in chewing efficiency would affect venous and lymphatic return, facilitating the entry of bacteria into the lymphatic circulation (Tsutsui et al., 2007; Nedergaard and Goldman, 2020).”
BackgroundSalehpour, F., Khademi, M., Евгеньевич, Б. Д., & DiDuro, J. O. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23062975 · Cited by 103 · see citing works
“Emerging evidence shows that sleep is the primary driver of glymphatic clearance and is essential for the maintenance of brain function via the discharge of metabolites and neurotoxic wastes from the brain, which accumulates in the highly active brain during waking hours [36,56].”
BackgroundAutonomic arousals contribute to brain fluid pulsations during sleep
Picchioni, D., Özbay, P. S., Mandelkow, H., de Zwart, J. A., Wang, Y., van Gelderen, P., & Duyn, J. H. (2022) · NeuroImage · doi:10.1016/j.neuroimage.2022.118888 · Cited by 103 · see citing works
Association of Sleep and β-Amyloid Pathology Among Older Cognitively Unimpaired Adults
Insel, P. S., Mohlenhoff, B. S., Neylan, T. C., Krystal, A. D., & Mackin, R. S. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.17573 · Cited by 97 · see citing works
Li, G., Cao, Y., Tang, X., Huang, J., Cai, L., & Zhou, L. (2022) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x221098145 · Cited by 99 · see citing works
“Numerous factors can affect glymphatic function, including sleep, chronic stress, and high alcohol intake.(162,163) Impaired glymphatic drainage has been shown to promote waste deposition: glymphatic failure is considered the point of convergence for various pathways leading to neurodegenerative dementia.”
BackgroundGlymphatic system: an emerging therapeutic approach for neurological disorders
Gao, Y., Liu, K., & Zhu, J. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1138769 · Cited by 104 · see citing works
“Previous studies have indicated that glymphatic flow and clearance activity decrease with aging and participate in a broad spectrum of diseases, especially those associated with sleep disturbance and neurological disorders with cognitive decline (Nedergaard and Goldman, 2020).”
BackgroundInfluentialImpact of multisession 40Hz tACS on hippocampal perfusion in patients with Alzheimer’s disease
Sprugnoli, G., Munsch, F., Cappon, D., Paciorek, R., Macone, J., Connor, A., El Fakhri, G., Salvador, R., Ruffini, G., Donohoe, K., et al. (2021) · Alzheimer's Research & Therapy · doi:10.1186/s13195-021-00922-4 · Cited by 99 · see citing works
“, the socalled glymphatic system, that seems to be impaired in AD mouse models and AD patients [13, 14].”
BackgroundTau-driven degeneration of sleep- and wake-regulating neurons in Alzheimer’s disease
Lew, C. H., Petersen, C., Neylan, T. C., & Grinberg, L. T. (2021) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2021.101541 · Cited by 95 · see citing works
Glymphatic Dysfunction Induced Oxidative Stress and Neuro-Inflammation in Major Depression Disorders
Gu, S., Li, Y., Jiang, Y., Huang, J. H., & Wang, F. (2022) · Antioxidants · doi:10.3390/antiox11112296 · Cited by 93 · see citing works
Cerebral small vessel disease: A glymphopathy?
Benveniste, H., & Nedergaard, M. (2021) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2021.07.006 · Cited by 92 · see citing works
Self-citationTseng, Y.-T., Zhao, B., Chen, S., Ye, J., Liu, J., Liang, L., Ding, H., Schaefke, B., Yang, Q., Wang, L., et al. (2022) · Neuron · doi:10.1016/j.neuron.2021.12.033 · Cited by 92 · see citing works
Vasciaveo, V., Iadarola, A., Casile, A., Dante, D., Morello, G., Minotta, L., Tamagno, E., Cicolin, A., & Guglielmotto, M. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01498-2 · Cited by 96 · see citing works
“The first pioneering studies documented that soluble amyloid beta protein and tau oligomers are transported from the interstitial fluid (ISF) space and out of the brain via the glymphatic system [62, 63].”
BackgroundGlymphatic System Impairment Contributes to the Formation of Brain Edema After Ischemic Stroke
Zhu, J., Mo, J., Liu, K., Chen, Q., Li, Z., He, Y., Chang, Y., Lin, C., Yu, M., Xu, Y., et al. (2024) · Stroke · doi:10.1161/strokeaha.123.045941 · Cited by 94 · see citing works
Sun, C., Lin, L., Yin, L., Hao, X., Tian, J., Zhang, X., Ren, Y., Li, C., & Yang, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.870029 · Cited by 91 · see citing works
“Besides, loss of AQP4 polarization impairs the glymphatic system, a newlydiscovered waste clearance system in the brain (17), causing toxic protein deposition and cognitive deficits (18, 19).”
BackgroundDefining circadian disruption in neurodegenerative disorders
Colwell, C. S. (2021) · Journal of Clinical Investigation · doi:10.1172/jci148288 · Cited by 90 · see citing works
“Importantly, the clearance of misfolded proteins is driven by sleep through the regulation of glymphatic flow (7).”
BackgroundEide, P. K., Pripp, A. H., Berge, B., Hrubos‐Strøm, H., Ringstad, G. A., & Valnes, L. M. (2022) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x221090747 · Cited by 91 · see citing works
“Ab and hyper-phosphorylated tau (HPs) aggregation in Alzheimer’s disease and aggregation of a-synuclein in Parkinson’s disease.(6) TBI may as well result in increased cerebral Ab and HPs burden and risk of Alzheimer’s.”
BackgroundGlymphatic dysfunction in patients with early-stage amyotrophic lateral sclerosis
Liu, S., Sun, X., Ren, Q., Chen, Y., Dai, T., Yang, Y., Gong, G., Li, W., Zhao, Y., Meng, X., et al. (2023) · Brain · doi:10.1093/brain/awad274 · Cited by 88 · see citing works
Glymphatic dysfunction in Alzheimer’s disease: A critical appraisal
Keil, S. A., Jansson, D., Braun, M., & Iliff, J. J. (2025) · Science · doi:10.1126/science.adv8269 · Cited by 96 · see citing works
Cai, X., Chen, Z., He, C., Zhang, P., Nie, K., Qiu, Y., Wang, L., Wang, L., Jing, P., & Zhang, Y. (2022) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13984 · Cited by 86 · see citing works
“MMSE, M (IQR) NA 28 (25, 29) NA 28 (24, 29) 28 (25, 29) 0.”
Aging biomarkers and the brain
Higgins‐Chen, A., Thrush, K., & Levine, M. E. (2021) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2021.01.003 · Cited by 86 · see citing works
Morawska, M. M., Moreira, C. G., Ginde, V. R., Valko, P. O., Weiß, T., Büchele, F., Imbach, L., Masneuf, S., Kollarik, S., Prymaczok, N. C., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abe7099 · Cited by 83 · see citing works
Impaired glymphatic function in idiopathic intracranial hypertension
Eide, P. K., Pripp, A. H., Ringstad, G. A., & Valnes, L. M. (2021) · Brain Communications · doi:10.1093/braincomms/fcab043 · Cited by 85 · see citing works
“It is therefore striking to note how distribution of areas with reduced molecular clearance in IIH match up with those most typically affected with amyloid-b and tau deposition in dementia diseases, including Alzheimer s disease.(20,30) There was no evidence of signal change in any brain region after 4 weeks, which in…”
BackgroundQin, Y., He, R., Chen, J., Zhou, X., Zhou, X. C., Liu, Z., Xu, Q., Guo, J., Yan, X., Jiang, N., et al. (2023) · Journal of Neurology · doi:10.1007/s00415-023-11594-5 · Cited by 85 · see citing works
Mehta, R. I., & Schneider, J. A. (2021) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000912 · Cited by 84 · see citing works
Zhang, Y., Zhang, R., Ye, Y., Wang, S., Jiaerken, Y., Hong, H., Li, K., Zeng, Q., Luo, X., Xu, X., et al. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.693787 · Cited by 84 · see citing works
Petitclerc, L., Hirschler, L., Wells, J. A., Thomas, D. L., van Walderveen, M. A. A., van Buchem, M. A., & van Osch, M. J. P. (2021) · NeuroImage · doi:10.1016/j.neuroimage.2021.118755 · Cited by 81 · see citing works
Bulk flow of cerebrospinal fluid observed in periarterial spaces is not an artifact of injection
Raghunandan, A., Ladrón-de-Guevara, A., Tithof, J., Mestre, H., Du, T., Nedergaard, M., Thomas, J. H., & Kelley, D. H. (2021) · eLife · doi:10.7554/elife.65958 · Cited by 82 · see citing works
Self-citationWilliams, S. D., Setzer, B., Fultz, N. E., Valdiviezo, Z., Tacugue, N., Diamandis, Z., & Lewis, L. D. (2023) · PLoS Biology · doi:10.1371/journal.pbio.3002035 · Cited by 86 · see citing works
The role of glymphatic system in the cerebral edema formation after ischemic stroke
Ji, C., Yu, X., Xu, W., Lenahan, C., Tu, S., & Shao, A. (2021) · Experimental Neurology · doi:10.1016/j.expneurol.2021.113685 · Cited by 82 · see citing works
Lemon, N. L., Canepa, E., Ilies, M. A., & Fossati, S. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.772278 · Cited by 84 · see citing works
“…and cognitive decline (Fossati et al., 2012b; Boland et al., 2018; Da Mesquita et al., 2018; Nortley et al., 2019; Provensi et al., 2019; Braun and Iliff, 2020; Carare et al., 2020; Cortes-Canteli and Iadecola, 2020; Nedergaard and Goldman, 2020; Parodi-Rullán et al., 2020; Quintana et al., 2021).”
BackgroundWen, J., Satyanarayanan, S. K., Li, A., Yan, L., Zhao, Z., Yuan, Q., Su, K., & Su, H. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.10.018 · Cited by 84 · see citing works
“Additionally, the glymphatic system, a waste clearance pathway within the brain, has gained increasing attention for its potential involvement in dementia-related protein accumulation and cognitive decline (Lohela et al., 2022; Nedergaard and Goldman, 2020).”
BackgroundKahle, K. T., Klinge, P. M., Koschnitzky, J. E., Kulkarni, A. V., MacAulay, N., Robinson, S., Schiff, S. J., & Strahle, J. M. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00519-9 · Cited by 81 · see citing works
“The exchange of solutes between interstitial fluid and CSF occurs at the ventricular wall and in the subarachnoid space 209,210 .”
Glymphatic function plays a protective role in ageing-related cognitive decline
Wang, J., Zhou, Y., Zhang, K., Wang, R., Xiao, Z., Zhong, W., Chen, Y., Li, J., Sun, J., & Lou, M. (2023) · Age and Ageing · doi:10.1093/ageing/afad107 · Cited by 80 · see citing works
“It has been shown that the deposition of pathological proteins could trigger neurotoxicity and inflammation [7, 32], and iron accumulation can compromise synaptic transmission and neuronal function [33].”
BackgroundImpaired Glymphatic and Meningeal Lymphatic Functions in Patients with Chronic Migraine
Wu, C., Chang, F., Wang, Y.-F., Lirng, J., Wu, H., Pan, L. H., Wang, S., & Chen, S. (2023) · Annals of Neurology · doi:10.1002/ana.26842 · Cited by 79 · see citing works
“Finally, we did not strictly control sleep quality 7 and posture 64 during the night before the MR examinations.”
BackgroundMethodInfluentialCarroll, J., Bower, J. E., & Ganz, P. A. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00580-3 · Cited by 79 · see citing works
The Effects of Light and the Circadian System on Rhythmic Brain Function
von Gall, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052778 · Cited by 79 · see citing works
“Importantly, glymphatic clearance might provide a link in the causal relationship between sleep disturbances and symptomatic progression in neurodegenerative diseases (reviewed in [98]).”
BackgroundLiu, G., Ladrón-de-Guevara, A., Izhiman, Y., Nedergaard, M., & Du, T. (2022) · Fluids and Barriers of the CNS · doi:10.1186/s12987-022-00382-4 · Cited by 79 · see citing works
Self-citationDhaynaut, M., Sprugnoli, G., Cappon, D., Macone, J., Sanchez, J. S., Normandin, M. D., Guehl, N. J., Koch, G., Paciorek, R., Connor, A., et al. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-215072 · Cited by 79 · see citing works
“Bitemporal tACS was conceived as a way to induce focal stimulation over the temporal lobes given the typical A (cid:2) and p-Tau protein distribution in these regions in the AD brain [6, 21], and on the basis of prior work by the PI using 40 Hz tACS in humans [15, 16, 22, 23].”
Municio, C., Carrero, L., Antequera, D., & Carro, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24010878 · Cited by 77 · see citing works
He, P., Shi, L., Li, Y., Duan, Q., Qiu, Y., Feng, S., Gao, Y., Luo, Y., Ma, G., Zhang, Y., et al. (2023) · Annals of Neurology · doi:10.1002/ana.26729 · Cited by 75 · see citing works
“8 Since the initial discovery of the glymphatic system in mouse central nervous systems by Iliff et al 9 using 2-photon microscopy in 2012, numerous detection techniques have been developed to evaluate the glymphatic system over the past decade.”
The Neurophysiology of Sleep in Parkinson's Disease
Zahed, H., Zuzuárregui, J. R. P., Gilron, R., Denison, T., Starr, P. A., & Little, S. J. (2021) · Movement Disorders · doi:10.1002/mds.28562 · Cited by 75 · see citing works
Parodi‐Rullán, R. M., Javadov, S. A., & Fossati, S. (2021) · Cells · doi:10.3390/cells10112903 · Cited by 75 · see citing works
Could dexmedetomidine be repurposed as a glymphatic enhancer?
Persson, N. D. Å., Uusalo, P., Nedergaard, M., Lohela, T. J., & Lilius, T. O. (2022) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2022.09.007 · Cited by 75 · see citing works
Self-citationPropagation of tau and α-synuclein in the brain: therapeutic potential of the glymphatic system
Lopes, D. M., Llewellyn, S. K., & Harrison, I. F. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00293-2 · Cited by 74 · see citing works
“Adding to this, sleep is crucially important for glymphatic clearance, which will be discussed later, and it is well established that sleep quality decreases with age, with insomnia, interrupted and superficial sleep as well as shorter sleep duration being common among older adults, causing a decline in nocturnal brai…”
BackgroundThe glymphatic system clears amyloid beta and tau from brain to plasma in humans
Dagum, P., Elbert, D. L., Giovangrandi, L., Singh, T., Venkatesh, V., Corbellini, A., Kaplan, R. M., Levendovszky, S. R., Ludington, E., Yarasheski, K. E., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-68374-8 · Cited by 87 · see citing works
Glymphatic system dysfunction in patients with juvenile myoclonic epilepsy
Lee, H., Lee, D. A., Shin, K. J., & Park, K. M. (2021) · Journal of Neurology · doi:10.1007/s00415-021-10799-w · Cited by 72 · see citing works
The inescapable drive to sleep: Overlapping mechanisms of sleep and sedation
Franks, N. P., & Wisden, W. (2021) · Science · doi:10.1126/science.abi8372 · Cited by 73 · see citing works
Astrocytes: The Housekeepers and Guardians of the CNS
Verkhratsky, A., Parpura, V., Li, B., & Scuderi, C. (2021) · Advances in neurobiology · doi:10.1007/978-3-030-77375-5_2 · Cited by 72 · see citing works
“In pathology, under stress or in ageing, the glymphatic subsystem is often impaired; deficient glymphatic clearance contributes to the pathophysiology of several brain disorders including neurodegenerative and psychiatric diseases (Liang et al. 2020; Nedergaard and Goldman 2020).”
BackgroundGlymphatic Dysfunction: A Bridge Between Sleep Disturbance and Mood Disorders
Yan, T., Qiu, Y., Yu, X., & Yang, L. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.658340 · Cited by 75 · see citing works
“Sleep disturbance (including shorter total sleep time, sleep fragmentation, and lack of NREM III) causes suppressed glymphatic function and a decline in the clearance of metabolic waste, hence contributing to the development and progression of various neurological diseases including AD (30), PD (31), stroke (32, 33),…”
BackgroundInfluentialChachaj, A., Gąsiorowski, K., Szuba, A., Sieradzki, A., & Leszek, J. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666220411091332 · Cited by 71 · see citing works
“Cardio-vascular health is crucial in the maintenance of brain inter-stitium homeostasis [83].”
Circadian and Sleep Dysfunctions in Neurodegenerative Disorders—An Update
Fifel, K., & Videnović, A. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.627330 · Cited by 68 · see citing works
“Clearance of amyloid or tau proteins by the glymphatic system may therefore be reduced on a background of disrupted sleep (Rasmussen et al., 2018; Nedergaard and Goldman, 2020).”
BackgroundEide, P. K., Lashkarivand, A., Pripp, A. H., Valnes, L. M., Hovd, M. H., Ringstad, G. A., Blennow, K., & Zetterberg, H. (2023) · Nature Communications · doi:10.1038/s41467-023-37685-5 · Cited by 69 · see citing works
“…showed a comparable reduc-tionofCSFproductionandturnoverinADandiNPHpatients 60 ,though CSF A β 40, A β 42,andT-/P-taualsowereable todifferentiateiNPH from AD subjects 61 . iNPH involves impaired glymphatic function 12,62 , which was proposed as a common mechanism behind dementias and AD 63 .”
A network model of glymphatic flow under different experimentally-motivated parametric scenarios
Tithof, J., Boster, K. A. S., Bork, P. A. R., Nedergaard, M., Thomas, J. H., & Kelley, D. H. (2022) · iScience · doi:10.1016/j.isci.2022.104258 · Cited by 67 · see citing works
“, 2017); multiple other studies (Morrison et al., 1994; Prabhu et al., 1998; Bobo et al., 1994; Neeves et al., 2006; Smith and Humphrey, 2007) have reported kpar values within these bounds.”
BackgroundSelf-citationTian, Y., Zhao, M., Chen, Y., Yang, M., & Wang, Y. (2022) · Biomolecules · doi:10.3390/biom12060748 · Cited by 69 · see citing works
“More importantly, the prion-like spread pattern of misfolded and aggregated protein was in keeping with the glymphatic flow reflected by neuroimaging [87].”
Result
- Authors
- Nedergaard, M., & Goldman, S. A.
- Affiliations
- University of Copenhagen (DK)
- Corresponding author
- Nedergaard, Maiken
- Goldman, Steven A.
- Venue
- Science
- Published
- 2020-10-02
- Volume
- 370
- Issue
- 6512
- Pages
- 50-56
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC8186542
- OpenAlex
- W3089407290
- Semantic Scholar
- 1581b29058a4261d11d32f29c0b5115b4594c81b
- Cited by
- 1,145
- References
- 116
- Citations by year
- 2026: 293 · 2025: 272 · 2024: 161 · 2023: 165 · 2022: 138 · 2021: 114 · 2020: 2
- FWCI
- 14.66
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- other-oa
- Locations
- Science (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, other-oa)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- European Commission (HORIZON2020)
- Lundbeckfonden (R155-2016-553, R155-2016–552)
- Novo Nordisk
- Novo Nordisk Fonden (NNF13OC0004258, NNF13OC0004260)
- H. Lundbeck A/S
- National Institute on Aging (RF1AG057575, RF1AG053991)
- National Institute of Mental Health (R01MH104701)
- National Institute of Neurological Disorders and Stroke (R01NS110776, RF1NS110049, R01NS100366)
- H2020 European Research Council (742112)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Cerebrospinal fluid and hydrocephalus
- Life Sciences › Neuroscience › Cognitive Neuroscience › Sleep and Wakefulness Research
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Keywords
- glymphatic system, dementia, sleep, sleep disorders, aging, neurodegenerative diseases, protein aggregation, brain waste clearance, sleep architecture, therapeutic target
- MeSH terms
- Prion Proteins, Glymphatic System, Aging, Alzheimer Disease, Animals, Cardiovascular Diseases, Humans, Lymphatic System, Polymorphism, Genetic, Sleep, Sleep Wake Disorders, Mice, Aquaporin 4, Protein Aggregates
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-05.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-05.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review